{"markup":"\u003C?xml version=\u00221.0\u0022 encoding=\u0022UTF-8\u0022 ?\u003E\n    \u003Chtml version=\u0022HTML+RDFa+MathML 1.1\u0022\n    xmlns:content=\u0022http:\/\/purl.org\/rss\/1.0\/modules\/content\/\u0022\n    xmlns:dc=\u0022http:\/\/purl.org\/dc\/terms\/\u0022\n    xmlns:foaf=\u0022http:\/\/xmlns.com\/foaf\/0.1\/\u0022\n    xmlns:og=\u0022http:\/\/ogp.me\/ns#\u0022\n    xmlns:rdfs=\u0022http:\/\/www.w3.org\/2000\/01\/rdf-schema#\u0022\n    xmlns:sioc=\u0022http:\/\/rdfs.org\/sioc\/ns#\u0022\n    xmlns:sioct=\u0022http:\/\/rdfs.org\/sioc\/types#\u0022\n    xmlns:skos=\u0022http:\/\/www.w3.org\/2004\/02\/skos\/core#\u0022\n    xmlns:xsd=\u0022http:\/\/www.w3.org\/2001\/XMLSchema#\u0022\n    xmlns:mml=\u0022http:\/\/www.w3.org\/1998\/Math\/MathML\u0022\u003E\n  \u003Chead\u003E\u003Cscript type=\u0022text\/javascript\u0022 src=\u0022\/\/cdn.jsdelivr.net\/qtip2\/2.2.1\/jquery.qtip.min.js\u0022\u003E\u003C\/script\u003E\n\u003Cscript type=\u0022text\/javascript\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/js\/js_YjAJQgxDlFX6S-O02jj9jCrVbrwlY3CGgCg1FzPlvBs.js\u0022\u003E\u003C\/script\u003E\n\u003Cscript type=\u0022text\/javascript\u0022\u003E\n\u003C!--\/\/--\u003E\u003C![CDATA[\/\/\u003E\u003C!--\nif(typeof window.MathJax === \u0022undefined\u0022) window.MathJax = { menuSettings: { zoom: \u0022Click\u0022 } };\n\/\/--\u003E\u003C!]]\u003E\n\u003C\/script\u003E\n\u003Cscript type=\u0022text\/javascript\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/js\/js_waP91NpgGpectm_6Y2XDEauLJ8WCSCBKmmA87unpp2E.js\u0022\u003E\u003C\/script\u003E\n\u003Cscript type=\u0022text\/javascript\u0022 src=\u0022https:\/\/www.googletagmanager.com\/gtag\/js?id=G-0K57TCX5BY\u0022\u003E\u003C\/script\u003E\n\u003Cscript type=\u0022text\/javascript\u0022\u003E\n\u003C!--\/\/--\u003E\u003C![CDATA[\/\/\u003E\u003C!--\nwindow.dataLayer = window.dataLayer || [];function gtag(){dataLayer.push(arguments)};gtag(\u0022js\u0022, new Date());gtag(\u0022set\u0022, \u0022developer_id.dMDhkMT\u0022, true);gtag(\u0022config\u0022, \u0022G-0K57TCX5BY\u0022, {\u0022groups\u0022:\u0022default\u0022,\u0022anonymize_ip\u0022:true});\n\/\/--\u003E\u003C!]]\u003E\n\u003C\/script\u003E\n\u003Cscript type=\u0022text\/javascript\u0022\u003E\n\u003C!--\/\/--\u003E\u003C![CDATA[\/\/\u003E\u003C!--\njQuery.extend(Drupal.settings, {\u0022basePath\u0022:\u0022\\\/\u0022,\u0022pathPrefix\u0022:\u0022\u0022,\u0022highwire\u0022:{\u0022ac\u0022:{\u0022medrxiv;2020.06.17.20133983v2\u0022:{\u0022access\u0022:{\u0022full\u0022:true},\u0022pisa_id\u0022:\u0022medrxiv;2020.06.17.20133983v2\u0022,\u0022apath\u0022:\u0022\u0022,\u0022jcode\u0022:\u0022medrxiv\u0022}},\u0022processed\u0022:[\u0022highwire_math\u0022],\u0022markup\u0022:[{\u0022requested\u0022:\u0022full-text\u0022,\u0022variant\u0022:\u0022full-text\u0022,\u0022view\u0022:\u0022full\u0022,\u0022pisa\u0022:\u0022medrxiv;2020.06.17.20133983v2\u0022}]},\u0022instances\u0022:\u0022{\\u0022highwire_abstract_tooltip\\u0022:{\\u0022content\\u0022:{\\u0022text\\u0022:\\u0022\\u0022},\\u0022style\\u0022:{\\u0022tip\\u0022:{\\u0022width\\u0022:20,\\u0022height\\u0022:20,\\u0022border\\u0022:1,\\u0022offset\\u0022:0,\\u0022corner\\u0022:true},\\u0022classes\\u0022:\\u0022qtip-custom hw-tooltip hw-abstract-tooltip qtip-shadow qtip-rounded\\u0022,\\u0022classes_custom\\u0022:\\u0022hw-tooltip hw-abstract-tooltip\\u0022},\\u0022position\\u0022:{\\u0022at\\u0022:\\u0022right center\\u0022,\\u0022my\\u0022:\\u0022left center\\u0022,\\u0022viewport\\u0022:true,\\u0022adjust\\u0022:{\\u0022method\\u0022:\\u0022shift\\u0022}},\\u0022show\\u0022:{\\u0022event\\u0022:\\u0022mouseenter click \\u0022,\\u0022solo\\u0022:true},\\u0022hide\\u0022:{\\u0022event\\u0022:\\u0022mouseleave \\u0022,\\u0022fixed\\u0022:1,\\u0022delay\\u0022:\\u0022100\\u0022}},\\u0022highwire_author_tooltip\\u0022:{\\u0022content\\u0022:{\\u0022text\\u0022:\\u0022\\u0022},\\u0022style\\u0022:{\\u0022tip\\u0022:{\\u0022width\\u0022:15,\\u0022height\\u0022:15,\\u0022border\\u0022:1,\\u0022offset\\u0022:0,\\u0022corner\\u0022:true},\\u0022classes\\u0022:\\u0022qtip-custom hw-tooltip hw-author-tooltip qtip-shadow qtip-rounded\\u0022,\\u0022classes_custom\\u0022:\\u0022hw-tooltip hw-author-tooltip\\u0022},\\u0022position\\u0022:{\\u0022at\\u0022:\\u0022top center\\u0022,\\u0022my\\u0022:\\u0022bottom center\\u0022,\\u0022viewport\\u0022:true,\\u0022adjust\\u0022:{\\u0022method\\u0022:\\u0022\\u0022}},\\u0022show\\u0022:{\\u0022event\\u0022:\\u0022mouseenter \\u0022,\\u0022solo\\u0022:true},\\u0022hide\\u0022:{\\u0022event\\u0022:\\u0022mouseleave \\u0022,\\u0022fixed\\u0022:1,\\u0022delay\\u0022:\\u0022100\\u0022}},\\u0022highwire_reflinks_tooltip\\u0022:{\\u0022content\\u0022:{\\u0022text\\u0022:\\u0022\\u0022},\\u0022style\\u0022:{\\u0022tip\\u0022:{\\u0022width\\u0022:15,\\u0022height\\u0022:15,\\u0022border\\u0022:1,\\u0022mimic\\u0022:\\u0022top center\\u0022,\\u0022offset\\u0022:0,\\u0022corner\\u0022:true},\\u0022classes\\u0022:\\u0022qtip-custom hw-tooltip hw-ref-link-tooltip qtip-shadow qtip-rounded\\u0022,\\u0022classes_custom\\u0022:\\u0022hw-tooltip hw-ref-link-tooltip\\u0022},\\u0022position\\u0022:{\\u0022at\\u0022:\\u0022bottom left\\u0022,\\u0022my\\u0022:\\u0022top left\\u0022,\\u0022viewport\\u0022:true,\\u0022adjust\\u0022:{\\u0022method\\u0022:\\u0022flip\\u0022}},\\u0022show\\u0022:{\\u0022event\\u0022:\\u0022mouseenter \\u0022,\\u0022solo\\u0022:true},\\u0022hide\\u0022:{\\u0022event\\u0022:\\u0022mouseleave \\u0022,\\u0022fixed\\u0022:1,\\u0022delay\\u0022:\\u0022100\\u0022}}}\u0022,\u0022qtipDebug\u0022:\u0022{\\u0022leaveElement\\u0022:0}\u0022,\u0022googleanalytics\u0022:{\u0022account\u0022:[\u0022G-0K57TCX5BY\u0022],\u0022trackOutbound\u0022:1,\u0022trackMailto\u0022:1,\u0022trackDownload\u0022:1,\u0022trackDownloadExtensions\u0022:\u00227z|aac|arc|arj|asf|asx|avi|bin|csv|doc(x|m)?|dot(x|m)?|exe|flv|gif|gz|gzip|hqx|jar|jpe?g|js|mp(2|3|4|e?g)|mov(ie)?|msi|msp|pdf|phps|png|ppt(x|m)?|pot(x|m)?|pps(x|m)?|ppam|sld(x|m)?|thmx|qtm?|ra(m|r)?|sea|sit|tar|tgz|torrent|txt|wav|wma|wmv|wpd|xls(x|m|b)?|xlt(x|m)|xlam|xml|z|zip\u0022,\u0022trackColorbox\u0022:1},\u0022ajaxPageState\u0022:{\u0022js\u0022:{\u0022\\\/\\\/cdn.jsdelivr.net\\\/qtip2\\\/2.2.1\\\/jquery.qtip.min.js\u0022:1,\u0022sites\\\/all\\\/modules\\\/highwire\\\/highwire\\\/plugins\\\/highwire_markup_process\\\/js\\\/highwire_article_reference_popup.js\u0022:1,\u0022sites\\\/all\\\/modules\\\/highwire\\\/highwire\\\/plugins\\\/highwire_markup_process\\\/js\\\/highwire_at_symbol.js\u0022:1,\u00220\u0022:1,\u0022sites\\\/all\\\/modules\\\/contrib\\\/google_analytics\\\/googleanalytics.js\u0022:1,\u0022https:\\\/\\\/www.googletagmanager.com\\\/gtag\\\/js?id=G-0K57TCX5BY\u0022:1,\u00221\u0022:1}}});\n\/\/--\u003E\u003C!]]\u003E\n\u003C\/script\u003E\n\u003Clink type=\u0022text\/css\u0022 rel=\u0022stylesheet\u0022 href=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/advagg_css\/css__dn-cpI1YtkU_iLHgA5WhlkxgYWyat_IxjF_B-WSYrpE__a9hIbt0eaZ7d5nhwnm2weG8R_2eXK4EvoOx9dOxouHE__QrrGUc7CpljPR5Aph-ukPbcwtK4AWrHGwCEXJ_k1V_c.css\u0022 media=\u0022all\u0022 \/\u003E\n\u003Clink type=\u0022text\/css\u0022 rel=\u0022stylesheet\u0022 href=\u0022\/\/cdn.jsdelivr.net\/qtip2\/2.2.1\/jquery.qtip.min.css\u0022 media=\u0022all\u0022 \/\u003E\n\u003Clink type=\u0022text\/css\u0022 rel=\u0022stylesheet\u0022 href=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/advagg_css\/css__HGACIFBlu2o05y3afvqlt5wrE_5Dn6MXsexfuEpeIwg__t4SOPxucAPoV3Os7g8dXqyMB1HRXQridRJ82X7nE33E__QrrGUc7CpljPR5Aph-ukPbcwtK4AWrHGwCEXJ_k1V_c.css\u0022 media=\u0022all\u0022 \/\u003E\n\u003Clink rel=\u0027stylesheet\u0027 type=\u0027text\/css\u0027 href=\u0027\/sites\/all\/modules\/contrib\/panels\/plugins\/layouts\/onecol\/onecol.css\u0027 \/\u003E\u003C\/head\u003E\u003Cbody\u003E\u003Cdiv class=\u0022panels-ajax-tab-panel panels-ajax-tab-panel-article-tab-full-text\u0022\u003E\u003Cdiv class=\u0022panel-display panel-1col clearfix\u0022 \u003E\n  \u003Cdiv class=\u0022panel-panel panel-col\u0022\u003E\n    \u003Cdiv\u003E\u003Cdiv class=\u0022panel-pane pane-highwire-markup\u0022 \u003E\n  \n      \n  \n  \u003Cdiv class=\u0022pane-content\u0022\u003E\n    \u003Cdiv class=\u0022highwire-markup\u0022\u003E\u003Cdiv xmlns=\u0022http:\/\/www.w3.org\/1999\/xhtml\u0022 data-highwire-cite-ref-tooltip-instance=\u0022highwire_reflinks_tooltip\u0022 class=\u0022content-block-markup\u0022 xmlns:xhtml=\u0022http:\/\/www.w3.org\/1999\/xhtml\u0022\u003E\u003Cdiv class=\u0022article fulltext-view \u0022\u003E\u003Cspan class=\u0022highwire-journal-article-marker-start\u0022\u003E\u003C\/span\u003E\u003Cdiv class=\u0022section abstract\u0022 id=\u0022abstract-1\u0022\u003E\u003Ch2 class=\u0022\u0022\u003EAbstract\u003C\/h2\u003E\u003Cp id=\u0022p-4\u0022\u003EEstimating the true magnitude of the United States (US) SARS-CoV-2 epidemic is crucial for understanding disease dynamics and, ultimately, for determining the effectiveness of interventions intended to interrupt transmission. We developed a Bayesian evidence synthesis model that explicitly accounts for reporting delays and secular variation in case ascertainment to generate estimates of incident COVID-19 infections on the basis of reported cases and deaths. We estimate time trends in COVID-19 epidemiology for every US state and county, from the first reported case (January 13, 2020) through January 1, 2021. Across counties, we estimate considerable variability in the level and pattern of incidence, producing major differences in the estimated proportion of the population infected by the end of 2020. Our estimates of COVID-19 deaths are consistent with independent estimates of excess mortality, and our estimates of cumulative incidence of infection are consistent with seroprevalence estimates from available antibody testing studies.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-1\u0022\u003E\u003Ch2 class=\u0022\u0022\u003EIntroduction\u003C\/h2\u003E\u003Cp id=\u0022p-17\u0022\u003EThe number of newly diagnosed cases and confirmed COVID-19 deaths are the most easily observed measures of the health burden associated with COVID-19, and have been widely used to track the trajectory of the epidemic.\u003Csup\u003E\u003Ca id=\u0022xref-ref-1-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-1\u0022\u003E1\u003C\/a\u003E,\u003Ca id=\u0022xref-ref-2-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-2\u0022\u003E2\u003C\/a\u003E\u003C\/sup\u003E However, there are at least three important limitations of using reported case and death counts to track the epidemic. First, testing is primarily organized to identify symptomatic individuals, and most individuals with asymptomatic infection will fail to be diagnosed. As asymptomatic disease represents a large fraction of all infections,\u003Csup\u003E\u003Ca id=\u0022xref-ref-3-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-3\u0022\u003E3\u003C\/a\u003E\u003C\/sup\u003E reported diagnoses will substantially underestimate the true incidence of infection. Second, the degree to which case counts undercount the true burden of disease is sensitive to the availability of diagnostic testing, which has also varied over time and geography.\u003Csup\u003E\u003Ca id=\u0022xref-ref-4-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-4\u0022\u003E4\u003C\/a\u003E,\u003Ca id=\u0022xref-ref-5-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-5\u0022\u003E5\u003C\/a\u003E,\u003Ca id=\u0022xref-ref-6-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-6\u0022\u003E6\u003C\/a\u003E\u003C\/sup\u003E For this reason, it is difficult to distinguish true disease trends from changes in testing practices. Third, case and death counts are lagging indicators of the transmission dynamics of the pathogen, as they are affected by delays associated with the disease incubation period, care-seeking behavior of symptomatic individuals, diagnostic processing times, and reporting practices.\u003C\/p\u003E\u003Cp id=\u0022p-18\u0022\u003EComplete estimates of COVID-19 cases and deaths provide insight into the size and scope of the United States (US) epidemic. From total infections, one can estimate the case ascertainment and how it has changed over the course of the epidemic, as well as the percentage of the population that has ever been infected with SARS-CoV-2. In addition, information describing trends in transmission can inform current and future COVID-19 control policies. A key metric for describing transmission changes is the effective reproduction number (\u003Cem\u003ER\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003Et\u003C\/em\u003E\u003C\/sub\u003E), which represents the average number of secondary infections caused by an infected individual at a given point in time.\u003Csup\u003E\u003Ca id=\u0022xref-ref-7-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-7\u0022\u003E7\u003C\/a\u003E\u003C\/sup\u003E \u003Cem\u003ER\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003Et\u003C\/em\u003E\u003C\/sub\u003E can signal short-term changes in transmission in response to policy and behavioral changes. However, estimates of \u003Cem\u003ER\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003Et\u003C\/em\u003E\u003C\/sub\u003E will be biased when the gaps and lags in reporting are inconsistent over time,\u003Csup\u003E\u003Ca id=\u0022xref-ref-5-2\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-5\u0022\u003E5\u003C\/a\u003E\u003C\/sup\u003E weakening its usefulness as a measure of transmission.\u003C\/p\u003E\u003Cp id=\u0022p-19\u0022\u003EHere, we present detailed estimates of COVID-19 trends for all US states and counties, based on a Bayesian evidence synthesis model that estimates SARS-CoV-2 infection patterns from observed case notifications and death reports. We apply our model to publicly available COVID-19 case and death data and report on the trajectory of the epidemic from the first reported case (January 13, 2020) until January 1, 2021. The model is available on GitHub (\u003Ca href=\u0022https:\/\/github.com\/covidestim\/covidestim\/\u0022\u003Ehttps:\/\/github.com\/covidestim\/covidestim\/\u003C\/a\u003E) as a package for the R programming language (\u003Cem\u003Ecovidestim\u003C\/em\u003E).\u201d\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-2\u0022\u003E\u003Ch2 class=\u0022\u0022\u003EResults\u003C\/h2\u003E\u003Cdiv id=\u0022sec-3\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EMain Findings\u003C\/h3\u003E\u003Cp id=\u0022p-20\u0022\u003EFrom the start of the epidemic until January 1, 2021 we estimated COVID-19 epidemiological outcomes from the time-series of cases and deaths in each US state and county, using a mechanistic model to account for changes in case ascertainment as well as delays associated with disease progression, diagnosis, and reporting systems. Counties and states are fit using an optimization routine that reports the \u003Cem\u003Emaximum a posteriori\u003C\/em\u003E estimate, which represents a best estimate of each outcome of interest, based on the available data.\u003C\/p\u003E\u003Cdiv id=\u0022sec-4\u0022 class=\u0022subsection\u0022\u003E\u003Ch4\u003EIncidence and R\u003Csub\u003Et\u003C\/sub\u003E\u003C\/h4\u003E\u003Cp id=\u0022p-21\u0022\u003ENationally, the COVID-19 epidemic has been characterized by three \u2018waves\u2019; however, different trends are observed at the state- and county-level (\u003Ca id=\u0022xref-fig-1-1\u0022 class=\u0022xref-fig\u0022 href=\u0022#F1\u0022\u003EFigure 1\u003C\/a\u003E). While the third wave was larger (in terms of total reported cases) nationally, the first wave was characterized by large localized epidemics. The largest number of new incident infections per capita in a single day nationally occurred on January 1 2021, when there were 255 new infections per 100,000. However, at the state level, incident infections peaked at 842 infections per 100,000 on March 24, 2020, in New York (\u003Ca id=\u0022xref-fig-2-1\u0022 class=\u0022xref-fig\u0022 href=\u0022#F2\u0022\u003EFigure 2\u003C\/a\u003E). On that day, 43.7% of all incident infections in the US occurred in New York State (163,732 total infections) and 29.1% of all US infections occurred in the five boroughs of New York City (108,739 infections). At the state level, the worst days of the pandemic (in terms of new infections per 100,000 residents) occurred between March 20 and April 1 in New York and New Jersey.\u003C\/p\u003E\u003Cdiv id=\u0022F1\u0022 class=\u0022fig pos-float type-figure  odd\u0022\u003E\u003Cdiv class=\u0022highwire-figure\u0022\u003E\u003Cdiv class=\u0022fig-inline-img-wrapper\u0022\u003E\u003Cdiv class=\u0022fig-inline-img\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2021\/04\/06\/2020.06.17.20133983\/F1.large.jpg?width=800\u0026amp;height=600\u0026amp;carousel=1\u0022 title=\u0022Panels 1-10: County-level infections per 100,000 population per day at 10 timepoints between April 1, 2020 and January 1, 2021. Panel 11: Time-series of national SARS-CoV-2 infection estimates (orange) and reported diagnoses (blue) per 100,000 people per day from March 1, 2020 to January 1, 2021. We assume that there were no reported cases or deaths prior to the first date indicated in the data.\u0022 class=\u0022highwire-fragment fragment-images colorbox-load\u0022 rel=\u0022gallery-fragment-images-898879841\u0022 data-figure-caption=\u0022\u0026lt;div class=\u0026quot;highwire-markup\u0026quot;\u0026gt;Panels 1-10: County-level infections per 100,000 population per day at 10 timepoints between April 1, 2020 and January 1, 2021. Panel 11: Time-series of national SARS-CoV-2 infection estimates (orange) and reported diagnoses (blue) per 100,000 people per day from March 1, 2020 to January 1, 2021. We assume that there were no reported cases or deaths prior to the first date indicated in the data.\u0026lt;\/div\u0026gt;\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003E\u003Cspan class=\u0022hw-responsive-img\u0022\u003E\u003Cimg class=\u0022highwire-fragment fragment-image lazyload\u0022 alt=\u0022Figure 1:\u0022 src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2021\/04\/06\/2020.06.17.20133983\/F1.medium.gif\u0022 width=\u0022440\u0022 height=\u0022354\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-fragment fragment-image\u0022 alt=\u0022Figure 1:\u0022 src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2021\/04\/06\/2020.06.17.20133983\/F1.medium.gif\u0022 width=\u0022440\u0022 height=\u0022354\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cul class=\u0022highwire-figure-links inline\u0022\u003E\u003Cli class=\u0022download-fig first\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2021\/04\/06\/2020.06.17.20133983\/F1.large.jpg?download=true\u0022 class=\u0022highwire-figure-link highwire-figure-link-download\u0022 title=\u0022Download Figure 1:\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EDownload figure\u003C\/a\u003E\u003C\/li\u003E\u003Cli class=\u0022new-tab last\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2021\/04\/06\/2020.06.17.20133983\/F1.large.jpg\u0022 class=\u0022highwire-figure-link highwire-figure-link-newtab\u0022 target=\u0022_blank\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EOpen in new tab\u003C\/a\u003E\u003C\/li\u003E\u003C\/ul\u003E\u003C\/div\u003E\u003Cdiv class=\u0022fig-caption\u0022 xmlns:xhtml=\u0022http:\/\/www.w3.org\/1999\/xhtml\u0022\u003E\u003Cspan class=\u0022fig-label\u0022\u003EFigure 1:\u003C\/span\u003E \u003Cp id=\u0022p-22\u0022 class=\u0022first-child\u0022\u003EPanels 1-10: County-level infections per 100,000 population per day at 10 timepoints between April 1, 2020 and January 1, 2021. Panel 11: Time-series of national SARS-CoV-2 infection estimates (orange) and reported diagnoses (blue) per 100,000 people per day from March 1, 2020 to January 1, 2021. We assume that there were no reported cases or deaths prior to the first date indicated in the data.\u003C\/p\u003E\u003Cdiv class=\u0022sb-div caption-clear\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv id=\u0022F2\u0022 class=\u0022fig pos-float type-figure  odd\u0022\u003E\u003Cdiv class=\u0022highwire-figure\u0022\u003E\u003Cdiv class=\u0022fig-inline-img-wrapper\u0022\u003E\u003Cdiv class=\u0022fig-inline-img\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2021\/04\/06\/2020.06.17.20133983\/F2.large.jpg?width=800\u0026amp;height=600\u0026amp;carousel=1\u0022 title=\u0022Incident infections per 100,000 residents per day (blue, left y-axis) and the percentage of the population ever-infected (red) for each US state from March 1, 2020 to January 1, 2021. Numbers in red indicate the percent ever-infected on January 1, 2021.\u0022 class=\u0022highwire-fragment fragment-images colorbox-load\u0022 rel=\u0022gallery-fragment-images-898879841\u0022 data-figure-caption=\u0022\u0026lt;div class=\u0026quot;highwire-markup\u0026quot;\u0026gt;Incident infections per 100,000 residents per day (blue, left y-axis) and the percentage of the population ever-infected (red) for each US state from March 1, 2020 to January 1, 2021. Numbers in red indicate the percent ever-infected on January 1, 2021.\u0026lt;\/div\u0026gt;\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003E\u003Cspan class=\u0022hw-responsive-img\u0022\u003E\u003Cimg class=\u0022highwire-fragment fragment-image lazyload\u0022 alt=\u0022Figure 2:\u0022 src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2021\/04\/06\/2020.06.17.20133983\/F2.medium.gif\u0022 width=\u0022440\u0022 height=\u0022338\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-fragment fragment-image\u0022 alt=\u0022Figure 2:\u0022 src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2021\/04\/06\/2020.06.17.20133983\/F2.medium.gif\u0022 width=\u0022440\u0022 height=\u0022338\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cul class=\u0022highwire-figure-links inline\u0022\u003E\u003Cli class=\u0022download-fig first\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2021\/04\/06\/2020.06.17.20133983\/F2.large.jpg?download=true\u0022 class=\u0022highwire-figure-link highwire-figure-link-download\u0022 title=\u0022Download Figure 2:\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EDownload figure\u003C\/a\u003E\u003C\/li\u003E\u003Cli class=\u0022new-tab last\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2021\/04\/06\/2020.06.17.20133983\/F2.large.jpg\u0022 class=\u0022highwire-figure-link highwire-figure-link-newtab\u0022 target=\u0022_blank\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EOpen in new tab\u003C\/a\u003E\u003C\/li\u003E\u003C\/ul\u003E\u003C\/div\u003E\u003Cdiv class=\u0022fig-caption\u0022\u003E\u003Cspan class=\u0022fig-label\u0022\u003EFigure 2:\u003C\/span\u003E \u003Cp id=\u0022p-23\u0022 class=\u0022first-child\u0022\u003EIncident infections per 100,000 residents per day (blue, left y-axis) and the percentage of the population ever-infected (red) for each US state from March 1, 2020 to January 1, 2021. Numbers in red indicate the percent ever-infected on January 1, 2021.\u003C\/p\u003E\u003Cdiv class=\u0022sb-div caption-clear\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cp id=\u0022p-24\u0022\u003EIn contrast, the largest number of incidence infections per capita in a single day during the second wave (June 6, 2020 \u2013 August 20, 2020) occurred in Arizona on June 29, 2020, when there were 284 new infections per 100,000. On this day, 9.6% of all US infections occurred in Arizona. The largest number of incidence infections per capita in a single day during the third wave (beginning October 1, 2020) occurred in South Dakota on November 8, 20201, when there were 649 new infections per 100,000. On this day, just 1.3% of all US infections occurred in South Dakota.\u003C\/p\u003E\u003Cp id=\u0022p-25\u0022\u003EAt the county-level, the largest number of new infections per 100,00 residents in a single day occurred on November 29, 2020 in Comanche County, KS (population 17,000), when we estimate there were 2342 new infections per 100,000 (40 new infections). Restricting this analysis to the 143 most populous counties where 50% of the US population lives,\u003Csup\u003E\u003Ca id=\u0022xref-ref-8-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-8\u0022\u003E8\u003C\/a\u003E\u003C\/sup\u003E the date with the highest incidence occurred on March 28, 2020 in Queens County, NY, when there were 1765 new infections per 100,000 population (39,791 new infections). The largest estimated number of new infections in a single day was 68,033 in Los Angeles County, California on December 28.\u003C\/p\u003E\u003Cp id=\u0022p-26\u0022\u003EFrom December 9, 2020 to January 1, 2021, Los Angeles County had the highest daily estimate of new SARS-CoV-2 infections of any county over the course of the epidemic.\u003C\/p\u003E\u003Cp id=\u0022p-27\u0022\u003EThe median state-level estimate of \u003Cem\u003ER\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003Et\u003C\/em\u003E\u003C\/sub\u003E on the first day a case was reported in each state was 3.63 (range: 1.93 in Washington to 8.26 in New York). By April, \u003Cem\u003ER\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003Et\u003C\/em\u003E\u003C\/sub\u003E estimates had dropped substantially; from April 1, 2020 to January 1, 2021, state-level estimates of \u003Cem\u003ER\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003Et\u003C\/em\u003E\u003C\/sub\u003E were between 0.56 and 1.68 (\u003Ca id=\u0022xref-fig-3-1\u0022 class=\u0022xref-fig\u0022 href=\u0022#F3\u0022\u003EFigure 3\u003C\/a\u003E). At the county level, \u003Cem\u003ER\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003Et\u003C\/em\u003E\u003C\/sub\u003E estimates were more variable after April 1, 2020, ranging from 0.35 (Wibaux County, MT on January 1, 2021) to 5.65 (Dakota County, NE on April 1, 2020).\u003C\/p\u003E\u003Cdiv id=\u0022F3\u0022 class=\u0022fig pos-float type-figure  odd\u0022\u003E\u003Cdiv class=\u0022highwire-figure\u0022\u003E\u003Cdiv class=\u0022fig-inline-img-wrapper\u0022\u003E\u003Cdiv class=\u0022fig-inline-img\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2021\/04\/06\/2020.06.17.20133983\/F3.large.jpg?width=800\u0026amp;height=600\u0026amp;carousel=1\u0022 title=\u0022Rt estimates for each US state from March 1, 2020 to January 1, 2021. Background colors indicate whether Rt is substantially greater than 1 (red), close to 1 (white), or substantially less than 1 (blue). Grey line indicates Rt = 1.\u0022 class=\u0022highwire-fragment fragment-images colorbox-load\u0022 rel=\u0022gallery-fragment-images-898879841\u0022 data-figure-caption=\u0022\u0026lt;div class=\u0026quot;highwire-markup\u0026quot;\u0026gt;\u0026lt;div xmlns=\u0026quot;http:\/\/www.w3.org\/1999\/xhtml\u0026quot;\u0026gt;\u0026lt;em\u0026gt;R\u0026lt;\/em\u0026gt;\u0026lt;sub\u0026gt;\u0026lt;em\u0026gt;t\u0026lt;\/em\u0026gt;\u0026lt;\/sub\u0026gt; estimates for each US state from March 1, 2020 to January 1, 2021. Background colors indicate whether \u0026lt;em\u0026gt;R\u0026lt;\/em\u0026gt;\u0026lt;sub\u0026gt;\u0026lt;em\u0026gt;t\u0026lt;\/em\u0026gt;\u0026lt;\/sub\u0026gt; is substantially greater than 1 (red), close to 1 (white), or substantially less than 1 (blue). Grey line indicates \u0026lt;em\u0026gt;R\u0026lt;\/em\u0026gt;\u0026lt;sub\u0026gt;\u0026lt;em\u0026gt;t\u0026lt;\/em\u0026gt;\u0026lt;\/sub\u0026gt; = 1.\u0026lt;\/div\u0026gt;\u0026lt;\/div\u0026gt;\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003E\u003Cspan class=\u0022hw-responsive-img\u0022\u003E\u003Cimg class=\u0022highwire-fragment fragment-image lazyload\u0022 alt=\u0022Figure 3:\u0022 src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2021\/04\/06\/2020.06.17.20133983\/F3.medium.gif\u0022 width=\u0022440\u0022 height=\u0022337\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-fragment fragment-image\u0022 alt=\u0022Figure 3:\u0022 src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2021\/04\/06\/2020.06.17.20133983\/F3.medium.gif\u0022 width=\u0022440\u0022 height=\u0022337\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cul class=\u0022highwire-figure-links inline\u0022\u003E\u003Cli class=\u0022download-fig first\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2021\/04\/06\/2020.06.17.20133983\/F3.large.jpg?download=true\u0022 class=\u0022highwire-figure-link highwire-figure-link-download\u0022 title=\u0022Download Figure 3:\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EDownload figure\u003C\/a\u003E\u003C\/li\u003E\u003Cli class=\u0022new-tab last\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2021\/04\/06\/2020.06.17.20133983\/F3.large.jpg\u0022 class=\u0022highwire-figure-link highwire-figure-link-newtab\u0022 target=\u0022_blank\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EOpen in new tab\u003C\/a\u003E\u003C\/li\u003E\u003C\/ul\u003E\u003C\/div\u003E\u003Cdiv class=\u0022fig-caption\u0022\u003E\u003Cspan class=\u0022fig-label\u0022\u003EFigure 3:\u003C\/span\u003E \u003Cp id=\u0022p-28\u0022 class=\u0022first-child\u0022\u003E\u003Cem\u003ER\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003Et\u003C\/em\u003E\u003C\/sub\u003E estimates for each US state from March 1, 2020 to January 1, 2021. Background colors indicate whether \u003Cem\u003ER\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003Et\u003C\/em\u003E\u003C\/sub\u003E is substantially greater than 1 (red), close to 1 (white), or substantially less than 1 (blue). Grey line indicates \u003Cem\u003ER\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003Et\u003C\/em\u003E\u003C\/sub\u003E = 1.\u003C\/p\u003E\u003Cdiv class=\u0022sb-div caption-clear\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-5\u0022 class=\u0022subsection\u0022\u003E\u003Ch4\u003EPercent Ever-Infected with SARS-CoV-2\u003C\/h4\u003E\u003Cp id=\u0022p-29\u0022\u003EFor each county, we calculated the percentage of the population ever-infected as the sum of all estimated infections divided by county population on January 1, 2021 (\u003Ca id=\u0022xref-fig-4-1\u0022 class=\u0022xref-fig\u0022 href=\u0022#F4\u0022\u003EFigure 4\u003C\/a\u003E). Nationally, we estimate that 26.7% of the US population had been infected with SARS-CoV-2 by January 1, 2021. Across states, the percent ever-infected ranged from 6.4% (Hawaii) to 45.9% (Arizona) (\u003Ca id=\u0022xref-fig-2-2\u0022 class=\u0022xref-fig\u0022 href=\u0022#F2\u0022\u003EFigure 2\u003C\/a\u003E). Across counties, the estimated percentage of the population ever-infected ranged from 0.8% (Kauai, HI) to 76.2% (Lamb County, TX). By January 1 2021, we found that the percent of the population ever-infected exceeded 50% in 241 (7.7%) counties and exceeded two-thirds of the population in just 22 (0.7%) counties. Conversely, the percent ever-infected was less than 10% in 145 (4.6%) counties and less than 5% in 34 (1.1%) counties.\u003C\/p\u003E\u003Cdiv id=\u0022F4\u0022 class=\u0022fig pos-float type-figure  odd\u0022\u003E\u003Cdiv class=\u0022highwire-figure\u0022\u003E\u003Cdiv class=\u0022fig-inline-img-wrapper\u0022\u003E\u003Cdiv class=\u0022fig-inline-img\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2021\/04\/06\/2020.06.17.20133983\/F4.large.jpg?width=800\u0026amp;height=600\u0026amp;carousel=1\u0022 title=\u0022Percentage of the population ever infected with SARS-CoV-2 as of January 1, 2021.\u0022 class=\u0022highwire-fragment fragment-images colorbox-load\u0022 rel=\u0022gallery-fragment-images-898879841\u0022 data-figure-caption=\u0022\u0026lt;div class=\u0026quot;highwire-markup\u0026quot;\u0026gt;Percentage of the population ever infected with SARS-CoV-2 as of January 1, 2021.\u0026lt;\/div\u0026gt;\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003E\u003Cspan class=\u0022hw-responsive-img\u0022\u003E\u003Cimg class=\u0022highwire-fragment fragment-image lazyload\u0022 alt=\u0022Figure 4:\u0022 src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2021\/04\/06\/2020.06.17.20133983\/F4.medium.gif\u0022 width=\u0022440\u0022 height=\u0022313\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-fragment fragment-image\u0022 alt=\u0022Figure 4:\u0022 src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2021\/04\/06\/2020.06.17.20133983\/F4.medium.gif\u0022 width=\u0022440\u0022 height=\u0022313\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cul class=\u0022highwire-figure-links inline\u0022\u003E\u003Cli class=\u0022download-fig first\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2021\/04\/06\/2020.06.17.20133983\/F4.large.jpg?download=true\u0022 class=\u0022highwire-figure-link highwire-figure-link-download\u0022 title=\u0022Download Figure 4:\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EDownload figure\u003C\/a\u003E\u003C\/li\u003E\u003Cli class=\u0022new-tab last\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2021\/04\/06\/2020.06.17.20133983\/F4.large.jpg\u0022 class=\u0022highwire-figure-link highwire-figure-link-newtab\u0022 target=\u0022_blank\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EOpen in new tab\u003C\/a\u003E\u003C\/li\u003E\u003C\/ul\u003E\u003C\/div\u003E\u003Cdiv class=\u0022fig-caption\u0022\u003E\u003Cspan class=\u0022fig-label\u0022\u003EFigure 4:\u003C\/span\u003E \u003Cp id=\u0022p-30\u0022 class=\u0022first-child\u0022\u003EPercentage of the population ever infected with SARS-CoV-2 as of January 1, 2021.\u003C\/p\u003E\u003Cdiv class=\u0022sb-div caption-clear\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cp id=\u0022p-31\u0022\u003EOn January 1, 2021, the US had reported 349,247 cumulative COVID-19 deaths.\u003Csup\u003E\u003Ca id=\u0022xref-ref-9-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-9\u0022\u003E9\u003C\/a\u003E\u003C\/sup\u003E For the same date, our analysis estimated 375,123 cumulative COVID-19 deaths, 7.4% greater than cumulative reported deaths and approximately 0.11% of the US population in 2019.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-6\u0022 class=\u0022subsection\u0022\u003E\u003Ch4\u003EProbability of Diagnosis\u003C\/h4\u003E\u003Cp id=\u0022p-32\u0022\u003EIn March and April 2020, the median probability of diagnosis for infected individuals across states was 11.8% (range: 3.4%, 49.0%) and 11.1% (range: 5.6%, 41.7%), respectively (\u003Ca id=\u0022xref-fig-5-1\u0022 class=\u0022xref-fig\u0022 href=\u0022#F5\u0022\u003EFigure 5\u003C\/a\u003E). Case ascertainment was lower than the national median in New York and New Jersey, where 6.9% and 4.9%, respectively, of infections were diagnosed and reported in March. Over the period March 1 to April 31, 2020, the median probability of diagnosis across the five boroughs of New York City was 5.3%; for every 1 reported case in New York City during this period, there were 20 SARS-CoV-2 infections.\u003C\/p\u003E\u003Cdiv id=\u0022F5\u0022 class=\u0022fig pos-float type-figure  odd\u0022\u003E\u003Cdiv class=\u0022highwire-figure\u0022\u003E\u003Cdiv class=\u0022fig-inline-img-wrapper\u0022\u003E\u003Cdiv class=\u0022fig-inline-img\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2021\/04\/06\/2020.06.17.20133983\/F5.large.jpg?width=800\u0026amp;height=600\u0026amp;carousel=1\u0022 title=\u0022The probability that a person infected with SARS-CoV-2 on a given day will be diagnosed (black) and the 7-day moving average of the fraction of COVID-19 antigen tests that are positive (red), for each US state from March 1, 2020 to January 1, 2021.\u0022 class=\u0022highwire-fragment fragment-images colorbox-load\u0022 rel=\u0022gallery-fragment-images-898879841\u0022 data-figure-caption=\u0022\u0026lt;div class=\u0026quot;highwire-markup\u0026quot;\u0026gt;The probability that a person infected with SARS-CoV-2 on a given day will be diagnosed (black) and the 7-day moving average of the fraction of COVID-19 antigen tests that are positive (red), for each US state from March 1, 2020 to January 1, 2021.\u0026lt;\/div\u0026gt;\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003E\u003Cspan class=\u0022hw-responsive-img\u0022\u003E\u003Cimg class=\u0022highwire-fragment fragment-image lazyload\u0022 alt=\u0022Figure 5:\u0022 src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2021\/04\/06\/2020.06.17.20133983\/F5.medium.gif\u0022 width=\u0022440\u0022 height=\u0022337\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-fragment fragment-image\u0022 alt=\u0022Figure 5:\u0022 src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2021\/04\/06\/2020.06.17.20133983\/F5.medium.gif\u0022 width=\u0022440\u0022 height=\u0022337\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cul class=\u0022highwire-figure-links inline\u0022\u003E\u003Cli class=\u0022download-fig first\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2021\/04\/06\/2020.06.17.20133983\/F5.large.jpg?download=true\u0022 class=\u0022highwire-figure-link highwire-figure-link-download\u0022 title=\u0022Download Figure 5:\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EDownload figure\u003C\/a\u003E\u003C\/li\u003E\u003Cli class=\u0022new-tab last\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2021\/04\/06\/2020.06.17.20133983\/F5.large.jpg\u0022 class=\u0022highwire-figure-link highwire-figure-link-newtab\u0022 target=\u0022_blank\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EOpen in new tab\u003C\/a\u003E\u003C\/li\u003E\u003C\/ul\u003E\u003C\/div\u003E\u003Cdiv class=\u0022fig-caption\u0022\u003E\u003Cspan class=\u0022fig-label\u0022\u003EFigure 5:\u003C\/span\u003E \u003Cp id=\u0022p-33\u0022 class=\u0022first-child\u0022\u003EThe probability that a person infected with SARS-CoV-2 on a given day will be diagnosed (black) and the 7-day moving average of the fraction of COVID-19 antigen tests that are positive (red), for each US state from March 1, 2020 to January 1, 2021.\u003C\/p\u003E\u003Cdiv class=\u0022sb-div caption-clear\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cp id=\u0022p-34\u0022\u003EFrom the introduction of SARS-CoV-2 in the US until July 1, 2020, there were approximately 7 infections for every reported case of SARS-CoV-2 nationally (14.0% of cases were diagnosed). Over the month of July, the median state probability of diagnosis was 32.4% (range: 12.6%, 49.34%). In areas with high incidence of SARS-Cov-2 infections during the second wave, ascertainment was lower than the national median; for example, the median probability of diagnosis in July was 16.6% (range: 11.8%, 18.2%) in Arizona and 13.6% (range: 10.6%, 24.9%) in Texas.\u003C\/p\u003E\u003Cp id=\u0022p-35\u0022\u003EFrom July 1, 2020 through January 1, 2021 the median state probability of diagnosis was 32.5% (range: 17.7%, 50.2%). From the beginning of the epidemic until January 1, 2021, we estimate that the median probability that a SARS-CoV-2 infection is diagnosed is 26.3%. We estimate that there have been 88.4 million SARS-CoV-2 infections as of January 1, 2021, far greater than the 20.0 million reported cases of COVID-19.\u003C\/p\u003E\u003Cp id=\u0022p-36\u0022\u003E\u003Ca id=\u0022xref-fig-5-2\u0022 class=\u0022xref-fig\u0022 href=\u0022#F5\u0022\u003EFigure 5\u003C\/a\u003E compares trends in the probability of diagnosis (estimated in this analysis) and the reported fraction of all COVID-19 antigen tests that were positive. These results indicate that the relationship between test positivity and probability of diagnosis is not a simple linear relationship, making test positivity an imperfect proxy for the level of undiagnosed disease in the community.\u003C\/p\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-7\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EComparisons to External Estimates\u003C\/h3\u003E\u003Cp id=\u0022p-37\u0022\u003EWe compared our estimates of the percent ever infected with SARS-CoV-2 to U.S. Centers for Disease Control (CDC) seroprevalence estimates based on commercial laboratory data.\u003Csup\u003E\u003Ca id=\u0022xref-ref-10-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-10\u0022\u003E10\u003C\/a\u003E\u003C\/sup\u003E Derived from a convenience sample of blood specimens collected for reasons unrelated to COVID-19, these estimates provide state-level evidence on SARS-CoV-2 antibody test positivity at multiple time points (\u003Ca id=\u0022xref-fig-6-1\u0022 class=\u0022xref-fig\u0022 href=\u0022#F6\u0022\u003EFigure 6\u003C\/a\u003E). However, these estimates are incomplete in some states (e.g. South Dakota) and the series deviate implausibly from the expectation of increasing seroprevalence over time in others (e.g. New York). Model estimates of the percent ever infected are higher than the CDC seroprevalence estimates for most states. Comparing these estimates to other reported indicators of cumulative disease burden on January 1 2021, the modelled estimates of the percent ever infected were more strongly correlated with cumulative hospitalizations (Spearman rank correlation (\u003Cem\u003E\u03c1\u003C\/em\u003E) = 0.63) and cumulative reported deaths (\u003Cem\u003E\u03c1\u003C\/em\u003E = 0.83) than the CDC seroprevalence estimates (\u003Cem\u003E\u03c1\u003C\/em\u003E = 0.41 and 0.37 for hospitalizations and deaths respectively).\u003C\/p\u003E\u003Cdiv id=\u0022F6\u0022 class=\u0022fig pos-float type-figure  odd\u0022\u003E\u003Cdiv class=\u0022highwire-figure\u0022\u003E\u003Cdiv class=\u0022fig-inline-img-wrapper\u0022\u003E\u003Cdiv class=\u0022fig-inline-img\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2021\/04\/06\/2020.06.17.20133983\/F6.large.jpg?width=800\u0026amp;height=600\u0026amp;carousel=1\u0022 title=\u0022Comparison of the estimated percent ever infected with SARS-CoV-2 (blue) to CDC seroprevalence estimates from commercial laboratory data (red) for each US state from August 1, 2020 to January 1, 2021.\u0022 class=\u0022highwire-fragment fragment-images colorbox-load\u0022 rel=\u0022gallery-fragment-images-898879841\u0022 data-figure-caption=\u0022\u0026lt;div class=\u0026quot;highwire-markup\u0026quot;\u0026gt;Comparison of the estimated percent ever infected with SARS-CoV-2 (blue) to CDC seroprevalence estimates from commercial laboratory data (red) for each US state from August 1, 2020 to January 1, 2021.\u0026lt;\/div\u0026gt;\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003E\u003Cspan class=\u0022hw-responsive-img\u0022\u003E\u003Cimg class=\u0022highwire-fragment fragment-image lazyload\u0022 alt=\u0022Figure 6:\u0022 src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2021\/04\/06\/2020.06.17.20133983\/F6.medium.gif\u0022 width=\u0022440\u0022 height=\u0022338\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-fragment fragment-image\u0022 alt=\u0022Figure 6:\u0022 src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2021\/04\/06\/2020.06.17.20133983\/F6.medium.gif\u0022 width=\u0022440\u0022 height=\u0022338\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cul class=\u0022highwire-figure-links inline\u0022\u003E\u003Cli class=\u0022download-fig first\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2021\/04\/06\/2020.06.17.20133983\/F6.large.jpg?download=true\u0022 class=\u0022highwire-figure-link highwire-figure-link-download\u0022 title=\u0022Download Figure 6:\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EDownload figure\u003C\/a\u003E\u003C\/li\u003E\u003Cli class=\u0022new-tab last\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2021\/04\/06\/2020.06.17.20133983\/F6.large.jpg\u0022 class=\u0022highwire-figure-link highwire-figure-link-newtab\u0022 target=\u0022_blank\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EOpen in new tab\u003C\/a\u003E\u003C\/li\u003E\u003C\/ul\u003E\u003C\/div\u003E\u003Cdiv class=\u0022fig-caption\u0022\u003E\u003Cspan class=\u0022fig-label\u0022\u003EFigure 6:\u003C\/span\u003E \u003Cp id=\u0022p-38\u0022 class=\u0022first-child\u0022\u003EComparison of the estimated percent ever infected with SARS-CoV-2 (blue) to CDC seroprevalence estimates from commercial laboratory data (red) for each US state from August 1, 2020 to January 1, 2021.\u003C\/p\u003E\u003Cdiv class=\u0022sb-div caption-clear\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cp id=\u0022p-39\u0022\u003EIn addition, we compared model estimates of cumulative COVID-19 deaths (detected and undetected) to state-level estimates of excess all-cause mortality\u003Csup\u003E\u003Ca id=\u0022xref-ref-6-2\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-6\u0022\u003E6\u003C\/a\u003E\u003C\/sup\u003E (\u003Ca id=\u0022xref-fig-7-1\u0022 class=\u0022xref-fig\u0022 href=\u0022#F7\u0022\u003EFigure 7\u003C\/a\u003E) at each weekly timepoint from March 7 to December 19, 2020. We expect COVID-19 deaths to follow trajectories similar to, but less than, estimated excess all-cause mortality, which also includes non-COVID-19 deaths linked to social disruption caused by the pandemic.\u003Csup\u003E\u003Ca id=\u0022xref-ref-6-3\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-6\u0022\u003E6\u003C\/a\u003E\u003C\/sup\u003E On average, the modeled estimate of cumulative COVID-19 deaths is less than or approximately equal to estimates of excess all-cause mortality. Notably, three states (Alaska, Hawaii, Maine) have extended periods where the all-cause mortality was not estimated to exceed all-cause mortality from previous years (i.e. excess mortality was negative); in periods where all-cause mortality is higher than expected, our estimates of COVID-19 deaths approximate the excess mortality estimates. Additionally, model estimates of cumulative COVID-19 deaths exceed estimates of excess all-cause mortality in two states (Massachusetts and Rhode Island). Estimates of excess all-cause mortality were not available for Connecticut, North Carolina, or West Virginia.\u003C\/p\u003E\u003Cdiv id=\u0022F7\u0022 class=\u0022fig pos-float type-figure  odd\u0022\u003E\u003Cdiv class=\u0022highwire-figure\u0022\u003E\u003Cdiv class=\u0022fig-inline-img-wrapper\u0022\u003E\u003Cdiv class=\u0022fig-inline-img\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2021\/04\/06\/2020.06.17.20133983\/F7.large.jpg?width=800\u0026amp;height=600\u0026amp;carousel=1\u0022 title=\u0022Comparison of cumulative COVID-19 deaths (blue) to cumulative excess all-cause mortality (red) for each US state from March 7 to December 19, 2020.\u0022 class=\u0022highwire-fragment fragment-images colorbox-load\u0022 rel=\u0022gallery-fragment-images-898879841\u0022 data-figure-caption=\u0022\u0026lt;div class=\u0026quot;highwire-markup\u0026quot;\u0026gt;Comparison of cumulative COVID-19 deaths (blue) to cumulative excess all-cause mortality (red) for each US state from March 7 to December 19, 2020.\u0026lt;\/div\u0026gt;\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003E\u003Cspan class=\u0022hw-responsive-img\u0022\u003E\u003Cimg class=\u0022highwire-fragment fragment-image lazyload\u0022 alt=\u0022Figure 7:\u0022 src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2021\/04\/06\/2020.06.17.20133983\/F7.medium.gif\u0022 width=\u0022440\u0022 height=\u0022338\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-fragment fragment-image\u0022 alt=\u0022Figure 7:\u0022 src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2021\/04\/06\/2020.06.17.20133983\/F7.medium.gif\u0022 width=\u0022440\u0022 height=\u0022338\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cul class=\u0022highwire-figure-links inline\u0022\u003E\u003Cli class=\u0022download-fig first\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2021\/04\/06\/2020.06.17.20133983\/F7.large.jpg?download=true\u0022 class=\u0022highwire-figure-link highwire-figure-link-download\u0022 title=\u0022Download Figure 7:\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EDownload figure\u003C\/a\u003E\u003C\/li\u003E\u003Cli class=\u0022new-tab last\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2021\/04\/06\/2020.06.17.20133983\/F7.large.jpg\u0022 class=\u0022highwire-figure-link highwire-figure-link-newtab\u0022 target=\u0022_blank\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EOpen in new tab\u003C\/a\u003E\u003C\/li\u003E\u003C\/ul\u003E\u003C\/div\u003E\u003Cdiv class=\u0022fig-caption\u0022\u003E\u003Cspan class=\u0022fig-label\u0022\u003EFigure 7:\u003C\/span\u003E \u003Cp id=\u0022p-40\u0022 class=\u0022first-child\u0022\u003EComparison of cumulative COVID-19 deaths (blue) to cumulative excess all-cause mortality (red) for each US state from March 7 to December 19, 2020.\u003C\/p\u003E\u003Cdiv class=\u0022sb-div caption-clear\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-8\u0022\u003E\u003Ch2 class=\u0022\u0022\u003EDiscussion\u003C\/h2\u003E\u003Cp id=\u0022p-41\u0022\u003EWe present detailed estimates of the time-course of SARS-CoV-2 infections in US states and counties over 2020, accounting for under-ascertainment and delays in reported outcomes. Case ascertainment varied over space and time; the probability that an infected individual is diagnosed was three times higher over July 1, 2020 to January 1, 2021 that it was over March 1, 2020 to July 1, 2020. Even as case ascertainment improved over the course of the epidemic, the probability of diagnosis typically decreased in jurisdictions experiencing a surge of new infections; a possible explanation is that testing availability still lags behind demand. Overall, we estimated that official case counts represent a fraction of total infections. As of January 1, 2021, we estimate that 26.7% of the US population has been infected with SARS-CoV-2 and 0.11% of the US population has died from their infection. The modeled estimates of the percent ever infected are higher than CDC seroprevalence estimates and more strongly correlated with cumulative hospitalizations and deaths across states, potentially reflecting biases in the empirical seroprevalence estimates. Specific limitations in the observed seroprevalence series include the use of non-representative samples,\u003Csup\u003E\u003Ca id=\u0022xref-ref-11-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-11\u0022\u003E11\u003C\/a\u003E\u003C\/sup\u003E and reduced sensitivity associated with waning of antibody titers, as has been reported for some tests.\u003Csup\u003E\u003Ca id=\u0022xref-ref-12-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-12\u0022\u003E12\u003C\/a\u003E,\u003Ca id=\u0022xref-ref-13-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-13\u0022\u003E13\u003C\/a\u003E\u003C\/sup\u003E The comparison between modeled estimates and seroprevalence data suggest that the model may add valuable information on the fraction of the population that has been infected over time, via synthesis of multiple data sources with adjustment for biases in various observation mechanisms.\u003C\/p\u003E\u003Cp id=\u0022p-42\u0022\u003EOur approach makes a number of simplifying assumptions related to delays in disease progression and detection. The model is parameterized to estimate only one geographic unit at a time, and we do not model spread of disease between counties or states. We deliberately use the same model assumptions and data for all geographies; we do not make use of additional data that might improve estimation (such as hospitalizations or wastewater-based surveillance) because these data were not available for all jurisdictions. Because we anchor the analysis on death data (under the assumption that deaths were more consistently reported over the course of the epidemic), model estimates are sensitive to infection fatality risk (IFR) estimates, which are themselves uncertain. Furthermore, we assume the completeness of death reporting is the same across jurisdictions. Finally, while our analysis describes epidemiological changes, it does not provide insight into the causes of these changes, such as changes to \u201csafer-at-home\u201d policies, indoor dining regulations, and mask mandates.\u003C\/p\u003E\u003Cp id=\u0022p-43\u0022\u003EBecause states report cases and deaths in different ways, there are there are a number of potential inconsistencies in these data, including exclusion of antigen test results, reporting the number of positive tests (as opposed to number of individuals who have tested positive), and inconsistent lags between detection and reporting. Rarely do available metadata indicate the presence, absence, or nature of these inconsistencies, which prevented specialized model configurations.\u003C\/p\u003E\u003Cp id=\u0022p-44\u0022\u003EAdditionally, data are subject to occasional revisions, which have frequently been implemented as a single-day change in the cumulative count of cases or deaths, without matching revisions to the historical time series. This leads to additional variance in the reported data, and a reduction in the precision of reported estimates.\u003C\/p\u003E\u003Cp id=\u0022p-45\u0022\u003EThe Bayesian estimation approach used for this analysis provides a coherent framework for simultaneously estimating the trend in SARS-CoV-2 incidence and the fraction of the population that has previously been infected, providing key information on the current status and past extent of state or county epidemics. In contrast to other approaches for estimating \u003Cem\u003ER\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003Et\u003C\/em\u003E\u003C\/sub\u003E and COVID-19 epidemiological outcomes for US states\u003Csup\u003E\u003Ca id=\u0022xref-ref-14-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-14\u0022\u003E14\u003C\/a\u003E,\u003Ca id=\u0022xref-ref-15-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-15\u0022\u003E15\u003C\/a\u003E\u003C\/sup\u003E and other countries,\u003Csup\u003E\u003Ca id=\u0022xref-ref-16-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-16\u0022\u003E16\u003C\/a\u003E\u003C\/sup\u003E our approach allows for time-trends in diagnostic coverage, which in turn allows for the extent of under-ascertainment to vary over the course of the epidemic. We have open-sourced and documented our \u003Cem\u003Ecovidestim\u003C\/em\u003E R package on GitHub, so that others can easily apply these methods to their own data.\u003C\/p\u003E\u003Cp id=\u0022p-46\u0022\u003EMathematical modelling has filled critical gaps in the evidence base for COVID-19 decision-making, and has been used to weigh the benefits of competing mitigation strategies, plan for the deployment of healthcare resources, and infer key features of COVID-19 natural history.\u003Csup\u003E\u003Ca id=\u0022xref-ref-14-2\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-14\u0022\u003E14\u003C\/a\u003E\u003C\/sup\u003E For the current study, we used modelling as a quantitative framework to synthesis multiple data sources and describe COVID-19 burden and trends for a large number of locations in the United States. A key finding of this work is that the has been no single US COVID-19 epidemic, but instead a large number of related epidemics, differing in their timing and magnitude even within individual states. While our study does not provide an explanation for the patterns of this epidemic, it demonstrates the need for explanations that are relevant at a fine geographic and temporal scale. The deployment of effective vaccines, and the spread of more transmissible COVID-19 variants, represent reasons for both hope and concern about future COVID-19 trends in the United States. Ongoing, locally-relevant evidence on these trends will continue to be important for both governmental and individual decision-making.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-9\u0022\u003E\u003Ch2 class=\u0022\u0022\u003EMethods\u003C\/h2\u003E\u003Cdiv id=\u0022sec-10\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EData\u003C\/h3\u003E\u003Cp id=\u0022p-47\u0022\u003EFor every state and county in the US, we extracted data on reported COVID-19 cases and deaths. We used state-level data on cumulative total cases and deaths compiled by the Covid Tracking Project\u003Csup\u003E\u003Ca id=\u0022xref-ref-18-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-18\u0022\u003E18\u003C\/a\u003E\u003C\/sup\u003E and county-level on cumulative total cases and deaths compiled by Johns Hopkins University.\u003Csup\u003E\u003Ca id=\u0022xref-ref-9-2\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-9\u0022\u003E9\u003C\/a\u003E\u003C\/sup\u003E We calculated new cases and deaths as the difference between the cumulative counts reported each day. For days in which the difference is below zero (for example, a data audit resulting in a downward revision of the cumulative count), we adjusted the difference to zero until the cumulative count rose above the previous maximum cumulative count, such that the cumulative count increases monotonically. For counties, we maintained this monotonic property, but allowed incident cases or deaths to rise immediately after a downward revision in the cumulative count.\u003C\/p\u003E\u003Cp id=\u0022p-48\u0022\u003EWe used state-specific age distributions of COVID-19 related deaths\u003Csup\u003E\u003Ca id=\u0022xref-ref-19-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-19\u0022\u003E19\u003C\/a\u003E\u003C\/sup\u003E and estimates of age-specific infection fatality risks\u003Csup\u003E\u003Ca id=\u0022xref-ref-20-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-20\u0022\u003E20\u003C\/a\u003E\u003C\/sup\u003E to estimate state-specific IFRs. Additionally, we used county-level estimates of the prevalence of one or more risk factors for severe COVID-19\u003Csup\u003E\u003Ca id=\u0022xref-ref-21-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-21\u0022\u003E21\u003C\/a\u003E\u003C\/sup\u003E to create county-specific IFRs, by multiplying the state IFR by the ratio of risk factor prevalence in each county relative to their state.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-11\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EAnalytic Overview\u003C\/h3\u003E\u003Cp id=\u0022p-49\u0022\u003EWe developed a mathematical model to estimate epidemiological measures COVID-19 based on the empirical data, accounting for under-ascertainment of cases and delays associated with care-seeking, disease progression, and reporting. We parameterized this model using available evidence, and used it to estimate SARS-CoV-2 infections and COVID-19 outcomes for all states and counties in the US. We constructed visualizations to help reveal patterns in these outcomes and a web interface to make the estimates broadly available.\u003C\/p\u003E\u003Cp id=\u0022p-50\u0022\u003ENewly infected and asymptomatic individuals may recover or progress to symptomatic disease with or without diagnosis. Individuals who progress to symptomatic, non-severe disease may recover or progress to severe disease with or without diagnosis. Finally, individuals with severe disease will either die or recover with or without diagnosis; only individuals who transit through severe disease can die. The model assumes fixed delays associated with disease progression and diagnosis, a time-varying probability of diagnosis, and complete reporting of diagnosed cases (with a fixed delay). Figure S1 shows modeled health states and possible transitions.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-12\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EInfection and Natural History\u003C\/h3\u003E\u003Cp id=\u0022p-51\u0022\u003EThe model estimates the time-series of SARS-CoV-2 effective reproduction numbers (R\u003Csub\u003Et\u003C\/sub\u003E) using a cubic b-spline, allowing for flexibility in the evolution of the epidemic curve over time. We estimated the change in new infections based on the value of R\u003Csub\u003Et\u003C\/sub\u003E on a given day and the serial interval. Specifically, the change in log(new infections) between two days was calculated as log(R\u003Csub\u003Et\u003C\/sub\u003E) divided by the serial interval. We also adjusted this value for the fraction of the population not yet infected, penalizing high values of R\u003Csub\u003Et\u003C\/sub\u003E in settings where a large fraction of the population is already infected. For an individual newly entering a given health state, their sojourn time in the health state is assumed to follow a fixed gamma distribution, and additional parameters describe the probability of further progression (versus recovery), upon exiting the health state.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-13\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EModeling Case Detection and Reporting\u003C\/h3\u003E\u003Cp id=\u0022p-52\u0022\u003EWe assumed that for a case to be reported, an individual must first be tested and the positive test result subsequently entered into the surveillance system. We assumed that for a death to be a confirmed COVID-19 death, an individual must be tested prior to their death and their death must be subsequently entered into the surveillance system. We modeled the delays associated with each of these steps separately \u2013 from symptom onset to test specimen collection, from symptom onset to death, from specimen collection to reporting, and from death to reporting.\u003C\/p\u003E\u003Cp id=\u0022p-53\u0022\u003EBecause data on reporting delays were not widely available, we assumed a fixed delay for the reporting of COVID-19 cases and deaths.\u003C\/p\u003E\u003Cp id=\u0022p-54\u0022\u003EThe probability of diagnosis conditional on entering the \u003Cem\u003ESevere\u003C\/em\u003E state is constant over the course of the epidemic. We assumed the probability of diagnosis in the \u003Cem\u003ESymptomatic\u003C\/em\u003E state can change over time and is always less than the probability of diagnosis in the \u003Cem\u003ESevere\u003C\/em\u003E state. We modeled a rate ratio of diagnosis at \u003Cem\u003ESymptomatic\u003C\/em\u003E compared to \u003Cem\u003ESevere\u003C\/em\u003E using a cubic b-spline; the time-varying probability of diagnosis at \u003Cem\u003ESymptomatic\u003C\/em\u003E is the product of this rate ratio and the probability of diagnosis at \u003Cem\u003ESevere\u003C\/em\u003E. Similarly, the probability of diagnosis in the \u003Cem\u003EAsymptomatic\u003C\/em\u003E state is the product of the probability of diagnosis in the \u003Cem\u003ESymptomatic\u003C\/em\u003E state and the time-varying rate ratio of diagnosis at \u003Cem\u003EAsymptomatic\u003C\/em\u003E compare to \u003Cem\u003ESymptomatic\u003C\/em\u003E, also modeled with a cubic b-spline. An individual in a given state on day \u003Cem\u003Ei\u003C\/em\u003E can be tested on day \u003Cem\u003Ei+j\u003C\/em\u003E, determined by a probability of receiving a test and an associated delay, which is a modeled proportion of sojourn time in that state. We assume that testing does not occur postmortem.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-14\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EModel priors\u003C\/h3\u003E\u003Cp id=\u0022p-55\u0022\u003EModel priors and inputs are presented in Table S1. We used informative priors and fixed distributions for parameters relating to the natural history of the disease, such as probability of disease progression and sojourn time in each state, respectively. The reporting delay is poorly identified by currently available case report data in most locations; we adopted log-normal prior distributions for the shape and rate parameters of these gamma distributions\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-15\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EModel implementation\u003C\/h3\u003E\u003Cp id=\u0022p-56\u0022\u003EThe model was implemented in R using the rstan package.\u003Csup\u003E\u003Ca id=\u0022xref-ref-22-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-22\u0022\u003E22\u003C\/a\u003E\u003C\/sup\u003E The model initializes 28 days before the first reported case or death. Given the delay from infection to death, we chose 28 days to allow the model to generate the necessary number of new infections to plausibly result in a death early in the observed time series. The model is fit to data from each county separately. Counties are fit using an optimization routine that reports the maximum a posteriori estimate, which represents an estimate of the mode of the posterior distribution of the model parameters. The optimization routine does not produce samples, and, therefore, we do not report credible intervals around model estimates.\u003C\/p\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section data-availability\u0022 id=\u0022sec-16\u0022\u003E\u003Ch2 class=\u0022\u0022\u003EData Availability\u003C\/h2\u003E\u003Cp id=\u0022p-57\u0022\u003EAll data used in the main analysis are available from The Covid Tracking Project and Johns Hopkins CSSE.\u003C\/p\u003E\u003Cp id=\u0022p-58\u0022\u003E\n\u003Ca href=\u0022https:\/\/covidtracking.com\/\u0022\u003Ehttps:\/\/covidtracking.com\/\u003C\/a\u003E\n\u003C\/p\u003E\u003Cp id=\u0022p-59\u0022\u003E\n\u003Ca href=\u0022https:\/\/www.mass.gov\/info-details\/covid-19-response-reporting\u0022\u003Ehttps:\/\/www.mass.gov\/info-details\/covid-19-response-reporting\u003C\/a\u003E\n\u003C\/p\u003E\u003Cp id=\u0022p-60\u0022\u003E\n\u003Ca href=\u0022https:\/\/github.com\/covidestim\/covidestim\u0022\u003Ehttps:\/\/github.com\/covidestim\/covidestim\u003C\/a\u003E\n\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-17\u0022\u003E\u003Ch2 class=\u0022\u0022\u003EFunding\u003C\/h2\u003E\u003Cp id=\u0022p-62\u0022\u003EKG reports grant from National Institutes of Health T32 GM007205 and Fogarty International Center D43 TW010540\u003C\/p\u003E\u003Cp id=\u0022p-63\u0022\u003EVEP reports grants from National Institute of Allergy and Infectious Diseases R01 AI137093 DMW reports grants from National Institute of Allergy and Infectious Diseases R01 AI137093 JLW reports grants from National Institute of Allergy and Infectious Diseases R01 AI137093 TC reports grants from National Institute of Allergy and Infectious Diseases R01 AI112438 NAM reports grants from National Institute of Allergy and Infectious Diseases R01 AI146555-01A1\u003C\/p\u003E\u003Cp id=\u0022p-64\u0022\u003EJAS reports funding from the Centers for Disease Control and Prevention though the Council of State and Territorial Epidemiologists (NU38OT000297-02) and the National Institute on Drug Abuse (3R37DA01561217S1).\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-18\u0022\u003E\u003Ch2 class=\u0022\u0022\u003EAuthor contributions\u003C\/h2\u003E\u003Cp id=\u0022p-65\u0022\u003EMHC developed the methodology, visualized the results, contributed to analysis, prepared the original manuscript, and edited the manuscript. MR designed the software, visualized results, prepared the original manuscript, and edited the manuscript. KG curated data and edited the manuscript. JH curated data and edited the manuscript. VEP contributed to the analysis and edited the manuscript. JAS contributed to the analysis and edited the manuscript. NS contributed to the analysis, prepared the original manuscript, and edited the manuscript. JLW contributed to the analysis and edited the manuscript. DMW contributed to the analysis and edited the manuscript. TC conceived the project, contributed to the analysis, prepared the original manuscript, and edited the manuscript. NAM conceived the project, developed the methodology, contributed to the analysis, prepared the original manuscript, and edited the manuscript.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-19\u0022\u003E\u003Ch2 class=\u0022\u0022\u003ECompeting interests\u003C\/h2\u003E\u003Cp id=\u0022p-66\u0022\u003EDMW has received consulting fees from Pfizer, Merck, GSK, and Affinivax for topics unrelated to this manuscript and is Principal Investigator on a research grant from Pfizer on an unrelated topic. VEP has received reimbursement from Merck and Pfizer for travel expenses to Scientific Input Engagements unrelated to the topic of this manuscript. All other authors have declared that no competing interest exist.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-20\u0022\u003E\u003Ch2 class=\u0022\u0022\u003EData and materials availability\u003C\/h2\u003E\u003Cp id=\u0022p-67\u0022\u003EAll data used in the main analysis are available for use at \u003Ca href=\u0022https:\/\/github.com\/covidestim\/covidestim-sources\u0022\u003Ehttps:\/\/github.com\/covidestim\/covidestim-sources\u003C\/a\u003E. The \u003Cem\u003Ecovidestim\u003C\/em\u003E package is available for download at \u003Ca href=\u0022https:\/\/github.com\/covidestim\/covidestim\u0022\u003Ehttps:\/\/github.com\/covidestim\/covidestim\u003C\/a\u003E.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-21\u0022\u003E\u003Ch2 class=\u0022\u0022\u003ESupplementary Materials\u003C\/h2\u003E\u003Cp id=\u0022p-68\u0022\u003ESupplementary Methods\u003C\/p\u003E\u003Cp id=\u0022p-69\u0022\u003ETable S1. Model Priors and Inputs\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-22\u0022\u003E\u003Ch2 class=\u0022\u0022\u003ESupplementary Materials\u003C\/h2\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-23\u0022\u003E\u003Ch3\u003ESupplementary Methods\u003C\/h3\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-24\u0022\u003E\u003Ch4\u003EState and county-level IFR estimates\u003C\/h4\u003E\u003Cp id=\u0022p-70\u0022\u003EWe estimated the IFR for each state based on the distribution of recorded COVID-19 deaths in the state\u003Csup\u003E\u003Ca id=\u0022xref-ref-23-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-23\u0022\u003E1\u003C\/a\u003E\u003C\/sup\u003E and age-specific IFR estimates.\u003Csup\u003E\u003Ca id=\u0022xref-ref-24-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-24\u0022\u003E2\u003C\/a\u003E\u003C\/sup\u003E For each state we divided the number of deaths in each age group by the IFR estimate for that age group, to produce the implied age distribution of infections. The state-average IFR was then calculated by averaging the age-specific IFR values, weighted by the implied fraction of infections in each age group. We rescaled these state-level values to produce a national average IFR value of 0.5%. As the age-distribution of COVID-19 deaths was not available at the county-level, we estimated county-level IFR values by multiplying the state-average IFR by the prevalence of comorbidities that predispose to COVID-19 mortality in the county\u003Csup\u003E\u003Ca id=\u0022xref-ref-25-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-25\u0022\u003E3\u003C\/a\u003E\u003C\/sup\u003E relative to the rest of the state. In addition, for all modelled locations we assumed higher IFR values earlier in the epidemic, reflecting deficiencies in diagnosis and care at this time. We parameterized this as a rate ratio applied to the probability of death among individuals with severe disease. This rate ratio declined from 2.34 [1.69, 3.19] at the beginning of 2020 to a value of 1.00 by the middle of the year, based on the ratio of reported COVID-19 deaths to hospitalizations prior to May 1 2020 compared to the subsequent 6 months. The time trend in this function was calculated as 1.0 minus the Normal Cumulative Distribution Function, centered on May 1 2020 with a standard deviation of 3 weeks.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-25\u0022\u003E\u003Ch4\u003EModel details\u003C\/h4\u003E\u003Cp id=\u0022p-71\u0022\u003EWe modeled the flow of infected individuals through four health states: asymptomatic and pre-symptomatic infection (\u003Cem\u003EAsymptomatic\u003C\/em\u003E), symptomatic disease that is mild to moderate and would not require hospitalization (\u003Cem\u003ESymptomatic\u003C\/em\u003E), severe disease that would likely require hospitalization (\u003Cem\u003ESevere\u003C\/em\u003E), and finally death (\u003Cem\u003EDeath\u003C\/em\u003E). Upon infection, all individuals enter the \u003Cem\u003EAsymptomatic\u003C\/em\u003E state. Gamma density functions describing the probability that an individual exits a health state \u003Cem\u003Ej\u003C\/em\u003E days after entering it are given by \u003Cem\u003E\u03b8\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003EAsySym,j\u003C\/em\u003E\u003C\/sub\u003E, \u003Cem\u003E\u03b8\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003ESymSev,j\u003C\/em\u003E\u003C\/sub\u003E, \u003Cem\u003E\u03b8\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003ESevDie,j\u003C\/em\u003E\u003C\/sub\u003E for \u003Cem\u003EAsymptomatic\u003C\/em\u003E (\u003Cem\u003EAsy\u003C\/em\u003E), \u003Cem\u003ESymptomatic\u003C\/em\u003E (\u003Cem\u003ESym\u003C\/em\u003E), and \u003Cem\u003ESevere\u003C\/em\u003E (\u003Cem\u003ESev\u003C\/em\u003E) states, respectively (where \u03b8\u003Csub\u003Ej\u003C\/sub\u003E represents the probability mass obtained by integrating the gamma density between \u003Cem\u003Ej\u003C\/em\u003E and \u003Cem\u003Ej+1\u003C\/em\u003E). The probability that an individual will progress from \u003Cem\u003EAsymptomatic\u003C\/em\u003E to \u003Cem\u003ESymptomatic\u003C\/em\u003E, from \u003Cem\u003ESymptomatic\u003C\/em\u003E to \u003Cem\u003ESevere\u003C\/em\u003E, and from \u003Cem\u003ESevere\u003C\/em\u003E to \u003Cem\u003EDeath\u003C\/em\u003E are given by \u003Cem\u003EP(Sym\u003C\/em\u003E|\u003Cem\u003EAsy), P(Sev\u003C\/em\u003E|\u003Cem\u003ESym)\u003C\/em\u003E, and \u003Cem\u003EP(Die\u003C\/em\u003E|\u003Cem\u003ESev)\u003C\/em\u003E, respectively:\n\u003Cspan class=\u0022disp-formula\u0022 id=\u0022disp-formula-1\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2021\/04\/06\/2020.06.17.20133983\/embed\/graphic-8.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2021\/04\/06\/2020.06.17.20133983\/embed\/graphic-8.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\n\n\u003C\/span\u003E\u003C\/p\u003E\u003Cp id=\u0022p-72\u0022\u003EThe number of individuals entering a health state on day \u003Cem\u003Ei+j\u003C\/em\u003E is equal to the product of the number of individuals on day \u003Cem\u003Ei\u003C\/em\u003E who could enter that state, the probability of entering the state, and the probability that they entered the health state on day \u003Cem\u003Ej\u003C\/em\u003E, summed over all \u003Cem\u003Ei,j\u003C\/em\u003E combinations. We assume a maximum possible sojourn time of 30 days for each disease state. The model is initialized 28 days prior to the first day for which data are available, given that observed data (diagnoses and deaths) are lagged relative to incidence.\u003C\/p\u003E\u003Cp id=\u0022p-73\u0022\u003EIndividuals can be diagnosed from any health state except \u003Cem\u003EDeath\u003C\/em\u003E. We assumed a time-invariant probability of diagnosis for individuals entering the \u003Cem\u003ESevere\u003C\/em\u003E state without a diagnosis, and time-varying probabilities of diagnosis for undiagnosed individuals in the \u003Cem\u003EAsymptomatic\u003C\/em\u003E and\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-26\u0022\u003E\u003Ch4\u003ESymptomatic states\u003C\/h4\u003E\u003Cp id=\u0022p-74\u0022\u003EThe time-varying probabilities were modeled with a rate-ratio and were restricted such that\n\u003Cspan class=\u0022disp-formula\u0022 id=\u0022disp-formula-2\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2021\/04\/06\/2020.06.17.20133983\/embed\/graphic-9.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2021\/04\/06\/2020.06.17.20133983\/embed\/graphic-9.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\n\n\u003C\/span\u003E\u003C\/p\u003E\u003Cp id=\u0022p-75\u0022\u003EWhere \u003Cem\u003EP(Dx\u003C\/em\u003E|\u003Cem\u003EAsy)\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003Ei\u003C\/em\u003E\u003C\/sub\u003E, \u003Cem\u003EP(Dx\u003C\/em\u003E|\u003Cem\u003ESym)\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003Ei\u003C\/em\u003E\u003C\/sub\u003E, and \u003Cem\u003EP(Dx\u003C\/em\u003E|\u003Cem\u003ESev)\u003C\/em\u003E are the probability of diagnosis for undiagnosed individuals in each state (i.e. total probability of diagnosis before they exit the health state). The number of newly-diagnosed individuals for a given health state on day \u003Cem\u003Ei+j\u003C\/em\u003E is equal to the product of the number of undiagnosed individuals entering a health state on day \u003Cem\u003Ei\u003C\/em\u003E, the probability of diagnosis from that state, and the probability that an individual will have been diagnosed on day \u003Cem\u003Ej\u003C\/em\u003E, summed over all \u003Cem\u003Ei,j\u003C\/em\u003E combinations:\n\u003Cspan class=\u0022disp-formula\u0022 id=\u0022disp-formula-3\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2021\/04\/06\/2020.06.17.20133983\/embed\/graphic-10.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2021\/04\/06\/2020.06.17.20133983\/embed\/graphic-10.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\n\n\u003C\/span\u003E\nwhere \u003Cem\u003EDxAsy DxSym\u003C\/em\u003E, and \u003Cem\u003EDxSev\u003C\/em\u003E are new diagnoses at \u003Cem\u003EAsymptomatic, Symptomatic\u003C\/em\u003E and \u003Cem\u003ESevere\u003C\/em\u003E, respectively, and \u003Cem\u003E\u03c1\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003EAsy,j\u003C\/em\u003E\u003C\/sub\u003E, \u003Cem\u003E\u03c1\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003ESym,j\u003C\/em\u003E\u003C\/sub\u003E and \u003Cem\u003E\u03c1\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003ESev,j\u003C\/em\u003E\u003C\/sub\u003E are the diagnostic delays. We model the cascade of outcomes after testing by the health state at which the individual was tested. Therefore, we estimated detected cases on day \u003Cem\u003Ei\u003C\/em\u003E as the sum of cases diagnosed in each health state on a given day \u003Cem\u003Ei\u003C\/em\u003E and detected deaths as the sum of cases diagnosed at any health state on any previous day that progress to \u003Cem\u003EDeath\u003C\/em\u003E on day \u003Cem\u003Ei\u003C\/em\u003E.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-27\u0022\u003E\u003Ch4\u003EData likelihood\u003C\/h4\u003E\u003Cp id=\u0022p-76\u0022\u003EWe used a negative binomial likelihood function for observed cases and deaths, with the mean values of these functions being the modeled estimate for each quantity. We estimated the expected number of cases reported on a given day as the convolution of the time series of detected cases and the reporting delay distribution for cases. A similar approach was used to estimate the expected number of deaths reported on a given day:\n\u003Cspan class=\u0022disp-formula\u0022 id=\u0022disp-formula-4\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2021\/04\/06\/2020.06.17.20133983\/embed\/graphic-11.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2021\/04\/06\/2020.06.17.20133983\/embed\/graphic-11.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\n\n\u003C\/span\u003E\nwhere \u003Cem\u003E\u03a8\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003Ej\u003C\/em\u003E\u003C\/sub\u003E is the probability of reporting \u003Cem\u003Ej\u003C\/em\u003E days after the event (testing or death) and \u003Cem\u003E\u03d5\u003C\/em\u003E is the negative binomial dispersion parameter. To account for variation in daily reported cases and deaths, we used a seven-day moving average of input data and modeled values in the likelihood function, and divided the value of the log-likelihood by the number of days in the moving average to avoid misrepresenting the strength of evidence.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-28\u0022\u003E\u003Ch4\u003Ecovidestim Package\u003C\/h4\u003E\u003Cp id=\u0022p-77\u0022\u003EThe \u003Cem\u003Ecovidestim\u003C\/em\u003E package is a package for the R programming language, suitable for public as well as research use. It can accommodate a number of data inputs. Users may enter a vector of daily case counts and\/or daily death counts. These data sources can be used in combination, so long as they are the same length and cover the same time period; days with no observed events may be represented with zeroes.\u003C\/p\u003E\u003Cp id=\u0022p-78\u0022\u003EThe package contains default model priors for progression probabilities and delays, detection probabilities and delays, and reporting delays associated with each data type. Users have the ability to override these defaults, though we recommend that they only specify priors for reporting delays; we do not recommend that users change default priors on parameters related to the natural history of COVID-19.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-29\u0022\u003E\u003Ch4\u003ECovidestim.org and code repositories\u003C\/h4\u003E\u003Cp id=\u0022p-79\u0022\u003EWe produce daily estimates of COVID-19 infections and the effective reproduction number of SARS-CoV-2 at the state-and county-levels at \u003Ca href=\u0022https:\/\/covidestim.org\u0022\u003Ehttps:\/\/covidestim.org\u003C\/a\u003E. To allow for daily production of model estimates for all U.S. counties and states, we developed several tools. The \u003Cem\u003Ecovidestim\u003C\/em\u003E Docker image is a container which allows for model execution in virtually any HPC or cloud environment, and is the easiest way to begin using the \u003Cem\u003Ecovidestim\u003C\/em\u003E R package, especially at scale. The \u003Cem\u003Ecovidestim-sources\u003C\/em\u003E repository enables automated, version-controlled, and reproducible data cleaning of four different case\/death data sources by leveraging Git\u2019s submodules feature. Finally, the \u003Cem\u003EdailyFlow\u003C\/em\u003E repository uses the Nextflow workflow engine\u003Csup\u003E\u003Ca id=\u0022xref-ref-26-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-26\u0022\u003E4\u003C\/a\u003E\u003C\/sup\u003E to clean the data, orchestrate 3200+ model runs within three supported execution environments (local, HPC, cloud), and export the results for research use and for web consumption. These repositories can be found at \u003Ca href=\u0022https:\/\/github.com\/covidestim\u0022\u003Ehttps:\/\/github.com\/covidestim\u003C\/a\u003E, have proved stable over roughly 400,000 cpu-hours of production use, and contain extensive documentation.\u003C\/p\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-30\u0022 class=\u0022subsection display-objects\u0022\u003E\u003Cdiv id=\u0022T1\u0022 class=\u0022table pos-float\u0022\u003E\u003Cdiv class=\u0022table-inline table-callout-links\u0022\u003E\u003Cdiv class=\u0022callout\u0022\u003E\u003Cspan\u003EView this table:\u003C\/span\u003E\u003Cul class=\u0022callout-links\u0022\u003E\u003Cli class=\u0022view-inline first\u0022\u003E\u003Ca href=\u0022\u0022 class=\u0022table-expand-inline\u0022 data-table-url=\u0022\/highwire\/markup\/330289\/expansion?postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed\u0026amp;table-expand-inline=1\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EView inline\u003C\/a\u003E\u003C\/li\u003E\u003Cli class=\u0022view-popup\u0022\u003E\u003Ca href=\u0022\/highwire\/markup\/330289\/expansion?width=1000\u0026amp;height=500\u0026amp;iframe=true\u0026amp;postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed\u0022 class=\u0022colorbox colorbox-load table-expand-popup\u0022 rel=\u0022gallery-fragment-tables\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EView popup\u003C\/a\u003E\u003C\/li\u003E\u003Cli class=\u0022download-ppt last\u0022\u003E\u003Ca href=\u0022\/highwire\/powerpoint\/330289\u0022 class=\u0022highwire-figure-link highwire-figure-link-ppt\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EDownload powerpoint\u003C\/a\u003E\u003C\/li\u003E\u003C\/ul\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv class=\u0022table-caption\u0022\u003E\u003Cspan class=\u0022table-label\u0022\u003ETable S1.\u003C\/span\u003E \u003Cp id=\u0022p-80\u0022 class=\u0022first-child\u0022\u003EModel Priors and Inputs\u003C\/p\u003E\u003Cdiv class=\u0022sb-div caption-clear\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section ack\u0022 id=\u0022ack-1\u0022\u003E\u003Ch2 class=\u0022\u0022\u003EAcknowledgments\u003C\/h2\u003E\u003Cp id=\u0022p-61\u0022\u003EWe thank Jeffrey Eaton for his thoughts on statistical analysis.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section fn-group\u0022 id=\u0022fn-group-1\u0022\u003E\u003Ch2\u003EFootnotes\u003C\/h2\u003E\u003Cul\u003E\u003Cli class=\u0022fn-others\u0022 id=\u0022fn-2\u0022\u003E\u003Cp id=\u0022p-2\u0022\u003E\u003Ca class=\u0022rev-xref\u0022 href=\u0022#xref-fn-2-1\u0022\u003E\u21b5\u003C\/a\u003E\u003Cspan class=\u0022fn-label\u0022\u003E\u0026amp;\u003C\/span\u003E These authors share senior authorship\u003C\/p\u003E\u003C\/li\u003E\u003C\/ul\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section ref-list\u0022 id=\u0022ref-list-1\u0022\u003E\u003Ch2 class=\u0022\u0022\u003EReferences\u003C\/h2\u003E\u003Col class=\u0022cit-list ref-use-labels\u0022\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E1.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-1-1\u0022 title=\u0022View reference 1. in text\u0022 id=\u0022ref-1\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-web\u0022 id=\u0022cit-2020.06.17.20133983v2.1\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth cit-collab\u0022\u003ECoronavirus in the U.S.: Latest Map and Case Count\u003C\/span\u003E. Retrieved from \u003Ca href=\u0022https:\/\/www.nytimes.com\/interactive\/2020\/us\/coronavirus-us-cases.html\u0022\u003Ehttps:\/\/www.nytimes.com\/interactive\/2020\/us\/coronavirus-us-cases.html\u003C\/a\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E2.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-2-1\u0022 title=\u0022View reference 2. in text\u0022 id=\u0022ref-2\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-web\u0022 id=\u0022cit-2020.06.17.20133983v2.2\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth cit-collab\u0022\u003ECoronavirus\u003C\/span\u003E. Retrieved from \u003Ca href=\u0022https:\/\/www.washingtonpost.com\/graphics\/2020\/national\/coronavirus-us-cases-deaths\/?itid=hp_pandemic%20test\u0022\u003Ehttps:\/\/www.washingtonpost.com\/graphics\/2020\/national\/coronavirus-us-cases-deaths\/?itid=hp_pandemic%20test\u003C\/a\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E3.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-3-1\u0022 title=\u0022View reference 3. in text\u0022 id=\u0022ref-3\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2020.06.17.20133983v2.3\u0022 data-doi=\u002210.7326\/M20-3012\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EOran\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ED.P.\u003C\/span\u003E\u003C\/span\u003E and \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ETopol\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EE.J.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-pub-date\u0022\u003E2020\u003C\/span\u003E. \u003Cspan class=\u0022cit-article-title\u0022\u003EPrevalence of asymptomatic SARS-CoV-2 infection: a narrative review\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EAnnals of internal medicine\u003C\/abbr\u003E, \u003Cspan class=\u0022cit-vol\u0022\u003E173\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E5\u003C\/span\u003E), pp.\u003Cspan class=\u0022cit-fpage\u0022\u003E362\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E367\u003C\/span\u003E.\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DAnnals%2Bof%2Binternal%2Bmedicine%26rft.volume%253D173%26rft.spage%253D362%26rft_id%253Dinfo%253Adoi%252F10.7326%252FM20-3012%26rft_id%253Dinfo%253Apmid%252Fhttp%253A%252F%252Fwww.n%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.7326\/M20-3012\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=http:\/\/www.n\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2021%2F04%2F06%2F2020.06.17.20133983.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E4.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-4-1\u0022 title=\u0022View reference 4. in text\u0022 id=\u0022ref-4\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2020.06.17.20133983v2.4\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EMDT\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EHitchings\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ENE\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EDean\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EB\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EGarcia-Carreras\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ETJ\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EHladish\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EAT\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EHuang\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EB\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EYang\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EDAT\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ECummings\u003C\/span\u003E\u003C\/span\u003E. \u003Cspan class=\u0022cit-article-title\u0022\u003EThe Usefulness Of SARS-CoV-2 Test-Positive Proportion As A Surveillance Tool\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EAmerican Journal of Epidemiology\u003C\/abbr\u003E, \u003Cspan class=\u0022cit-pub-date\u0022\u003E2021\u003C\/span\u003E, \u003Ca href=\u0022https:\/\/doi.org\/10.1093\/aje\/kwab023\u0022\u003Ehttps:\/\/doi.org\/10.1093\/aje\/kwab023\u003C\/a\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E5.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-5-1\u0022 title=\u0022View reference 5. in text\u0022 id=\u0022ref-5\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2020.06.17.20133983v2.5\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EVE\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EPitzer\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EMH\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EChitwood\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EJ\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EHavumaki\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ENA\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EMenzies\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ES\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EPerniciaro\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EJL\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EWarren\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E, \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EThe impact of changes in diagnostic testing practices on estimates of COVID-19 transmission in the United States. [Preprint]\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-pub-date\u0022\u003E2020\u003C\/span\u003E [Cited 2020 July 13]. Available from: \u003Ca href=\u0022https:\/\/doi.org\/10.1101\/2020.04.20.20073338\u0022\u003Ehttps:\/\/doi.org\/10.1101\/2020.04.20.20073338\u003C\/a\u003E.\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E6.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-6-1\u0022 title=\u0022View reference 6. in text\u0022 id=\u0022ref-6\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-web\u0022 id=\u0022cit-2020.06.17.20133983v2.6\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ED\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EWeinberger\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ET\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ECohen\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EF\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ECrawford\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EF\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EMostashari\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ED\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EOlson\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EVE\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EPitzer\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E, \u003Cspan class=\u0022cit-source\u0022\u003EEstimating the early death toll of COVID-19 in the United States. [Preprint]\u003C\/span\u003E. \u003Cspan class=\u0022cit-pub-date\u0022\u003E2020\u003C\/span\u003E [Cited 2020 July 13] Available from: \u003Ca href=\u0022https:\/\/doi.org\/10.1101\/2020.04.15.20066431\u0022\u003Ehttps:\/\/doi.org\/10.1101\/2020.04.15.20066431\u003C\/a\u003E.\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E7.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-7-1\u0022 title=\u0022View reference 7. in text\u0022 id=\u0022ref-7\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2020.06.17.20133983v2.7\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EKM\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EGostic\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EL\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EMcGough\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EE\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EBaskerville\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ES\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EAbbott\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EK\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EJoshi\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EC\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ETedijanto\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EPractical considerations for measuring the effective reproductive number, Rt\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EPLoS Comput. Biol\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-vol\u0022\u003E16\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E12\u003C\/span\u003E): \u003Cspan class=\u0022cit-fpage\u0022\u003Ee1008409\u003C\/span\u003E. \u003Ca href=\u0022https:\/\/doi.org\/10.1371\/journal.pcbi.1008409\u0022\u003Ehttps:\/\/doi.org\/10.1371\/journal.pcbi.1008409\u003C\/a\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E8.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-8-1\u0022 title=\u0022View reference 8. in text\u0022 id=\u0022ref-8\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-web\u0022 id=\u0022cit-2020.06.17.20133983v2.8\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EH El\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ENasser\u003C\/span\u003E\u003C\/span\u003E. \u003Cspan class=\u0022cit-source\u0022\u003EMore Than Half of U.S. Population in 4.6 Percent of Counties\u003C\/span\u003E. \u003Cspan class=\u0022cit-month\u0022\u003EOctober\u003C\/span\u003E \u003Cspan class=\u0022cit-day\u0022\u003E4\u003C\/span\u003E, \u003Cspan class=\u0022cit-pub-date\u0022\u003E2017\u003C\/span\u003E. Retrieved from: \u003Ca href=\u0022https:\/\/www.census.gov\/library\/stories\/2017\/10\/big-and-small-counties.html\u0022\u003Ehttps:\/\/www.census.gov\/library\/stories\/2017\/10\/big-and-small-counties.html\u003C\/a\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E9.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-9-1\u0022 title=\u0022View reference 9. in text\u0022 id=\u0022ref-9\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-web\u0022 id=\u0022cit-2020.06.17.20133983v2.9\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth cit-collab\u0022\u003ECOVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University\u003C\/span\u003E. [Cited 15 January 2021] Available at: \u003Ca href=\u0022https:\/\/coronavirus.jhu.edu\/map.html\u0022\u003Ehttps:\/\/coronavirus.jhu.edu\/map.html\u003C\/a\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E10.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-10-1\u0022 title=\u0022View reference 10. in text\u0022 id=\u0022ref-10\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-web\u0022 id=\u0022cit-2020.06.17.20133983v2.10\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth cit-collab\u0022\u003ENationwide Commercial Laboratory Seroprevalence Survey\u003C\/span\u003E. [Cited 23 March, 2020] Available at: \u003Ca href=\u0022https:\/\/data.cdc.gov\/Laboratory-Surveillance\/Nationwide-Commercial-Laboratory-Seroprevalence-Su\/d2tw-32xv\u0022\u003Ehttps:\/\/data.cdc.gov\/Laboratory-Surveillance\/Nationwide-Commercial-Laboratory-Seroprevalence-Su\/d2tw-32xv\u003C\/a\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E11.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-11-1\u0022 title=\u0022View reference 11. in text\u0022 id=\u0022ref-11\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2020.06.17.20133983v2.11\u0022 data-doi=\u002210.1001\/jamainternmed.2020.7976\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EBajema\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EKL\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EWiegand\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ERE\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ECuffe\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EK\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EEstimated SARS-CoV-2 Seroprevalence in the US as of September 2020\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EJAMA Intern Med\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-month\u0022\u003ENovember\u003C\/span\u003E \u003Cspan class=\u0022cit-day\u0022\u003E24\u003C\/span\u003E, \u003Cspan class=\u0022cit-pub-date\u0022\u003E2020\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1001\/jamainternmed.2020.7976\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DJAMA%2BIntern%2BMed%26rft_id%253Dinfo%253Adoi%252F10.1001%252Fjamainternmed.2020.7976%26rft_id%253Dinfo%253Apmid%252F33231628%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1001\/jamainternmed.2020.7976\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=33231628\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2021%2F04%2F06%2F2020.06.17.20133983.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E12.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-12-1\u0022 title=\u0022View reference 12. in text\u0022 id=\u0022ref-12\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2020.06.17.20133983v2.12\u0022 data-doi=\u002210.1056\/NEJMc2025179\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EFJ\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EIbarrondo\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EJA\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EFulcher\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ED\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003Egoodman-Meza\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003ERapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EN Engl J Med\u003C\/abbr\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2020\u003C\/span\u003E; \u003Cspan class=\u0022cit-vol\u0022\u003E383\u003C\/span\u003E:\u003Cspan class=\u0022cit-fpage\u0022\u003E1085\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E1087\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003EDOI: \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1056\/NEJMc2025179\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DN%2BEngl%2BJ%2BMed%26rft_id%253Dinfo%253Adoi%252F10.1056%252FNEJMc2025179%26rft_id%253Dinfo%253Apmid%252F32706954%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1056\/NEJMc2025179\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=32706954\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2021%2F04%2F06%2F2020.06.17.20133983.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E13.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-13-1\u0022 title=\u0022View reference 13. in text\u0022 id=\u0022ref-13\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2020.06.17.20133983v2.13\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EJ\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ESeow\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EC\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EGraham\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EB\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EMerrick\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003ELongitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003ENat Microbiol\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E5\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E1598\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E1607\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2020\u003C\/span\u003E). \u003Ca href=\u0022https:\/\/doi.org\/10.1038\/s41564-020-00813-8\u0022\u003Ehttps:\/\/doi.org\/10.1038\/s41564-020-00813-8\u003C\/a\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DNat%2BMicrobiol%26rft.volume%253D5%26rft.spage%253D1598%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E14.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-14-1\u0022 title=\u0022View reference 14. in text\u0022 id=\u0022ref-14\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2020.06.17.20133983v2.14\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EHJT\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EUnwin\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ES\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EMishra\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EVC\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EBradley\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EA\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EGandy\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EM\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EVollmer\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ET\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EMellan\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E, \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EReport 23: state-level tracking of COVID-19 in the United States - version 2 (28-05-2020)\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-pub-date\u0022\u003E2020\u003C\/span\u003E. doi: \u003Ca href=\u0022https:\/\/doi.org\/10.25561\/79231\u0022\u003Ehttps:\/\/doi.org\/10.25561\/79231\u003C\/a\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E15.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-15-1\u0022 title=\u0022View reference 15. in text\u0022 id=\u0022ref-15\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-web\u0022 id=\u0022cit-2020.06.17.20133983v2.15\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth cit-collab\u0022\u003ECOVID-19 Portal\u003C\/span\u003E, \u003Cspan class=\u0022cit-source\u0022\u003ECenter for the Ecology of Infection Diseases, University of Georgia\u003C\/span\u003E [Cited 2020 July 13]. Available at: \u003Ca href=\u0022https:\/\/www.covid19.uga.edu\/nowcast.html\u0022\u003Ehttps:\/\/www.covid19.uga.edu\/nowcast.html\u003C\/a\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E16.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-16-1\u0022 title=\u0022View reference 16. in text\u0022 id=\u0022ref-16\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2020.06.17.20133983v2.16\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ES\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EFlaxman\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ES\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EMishra\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EA\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EGandy\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EHJT\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EUwin\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EH\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ECoupland\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ETA\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EMellan\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E, \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EReport 13: estimating the number of infections and the impact of non-pharmaceutical interventions on COVID-19 in 11 European countries\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-pub-date\u0022\u003E2020\u003C\/span\u003E. doi: \u003Ca href=\u0022https:\/\/doi.org\/10.25561\/77731\u0022\u003Ehttps:\/\/doi.org\/10.25561\/77731\u003C\/a\u003E.\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E17.\u003C\/span\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal no-rev-xref\u0022 id=\u0022cit-2020.06.17.20133983v2.17\u0022 data-doi=\u002210.1177\/0272989X21990391\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ELP\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EJames\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EJA\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ESalomon\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ECO\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EBuckee\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ENA\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EMenzies\u003C\/span\u003E\u003C\/span\u003E. \u003Cspan class=\u0022cit-article-title\u0022\u003EThe Use and Misuse of Mathematical Modeling for Infectious Disease Policymaking: Lessons for the OCIVD-19 Pandemic\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EMed. Decis. Making\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-pub-date\u0022\u003E2021\u003C\/span\u003E \u003Cspan class=\u0022cit-month\u0022\u003EFeb\u003C\/span\u003E 3;272989X21990391.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi: \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1177\/0272989X21990391\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DMed.%2BDecis.%2BMaking%26rft_id%253Dinfo%253Adoi%252F10.1177%252F0272989X21990391%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1177\/0272989X21990391\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E18.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-18-1\u0022 title=\u0022View reference 18. in text\u0022 id=\u0022ref-18\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-web\u0022 id=\u0022cit-2020.06.17.20133983v2.18\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth cit-collab\u0022\u003EThe COVID Tracking Project\u003C\/span\u003E. [Cited 15 January 2021] Available at: \u003Ca href=\u0022https:\/\/covidtracking.com\/\u0022\u003Ehttps:\/\/covidtracking.com\/\u003C\/a\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E19.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-19-1\u0022 title=\u0022View reference 19. in text\u0022 id=\u0022ref-19\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-web\u0022 id=\u0022cit-2020.06.17.20133983v2.19\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth cit-collab\u0022\u003ENational Center for Health Statistics\u003C\/span\u003E. \u003Cspan class=\u0022cit-source\u0022\u003E\u201cProvisional COVID-19 Death Counts by Sex, Age, and State\u201d\u003C\/span\u003E [Cited 15 January 2021] Available at: \u003Ca href=\u0022https:\/\/data.cdc.gov\/NCHS\/Provisional-COVID-19-Death-Counts-by-Sex-Age-and-S\/9bhg-hcku\u0022\u003Ehttps:\/\/data.cdc.gov\/NCHS\/Provisional-COVID-19-Death-Counts-by-Sex-Age-and-S\/9bhg-hcku\u003C\/a\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E20.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-20-1\u0022 title=\u0022View reference 20. in text\u0022 id=\u0022ref-20\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2020.06.17.20133983v2.20\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EO\u2019Driscoll\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EM.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ERibeiro Dos Santos\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EG.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EWang\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EL.\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EAge-specific mortality and immunity patterns of SARS-CoV-2\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003ENature\u003C\/abbr\u003E\u003Cspan class=\u0022cit-vol\u0022\u003E590\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E140\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E145\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2021\u003C\/span\u003E). \u003Ca href=\u0022https:\/\/doi.org\/10.1038\/s41586-020-2918-0\u0022\u003Ehttps:\/\/doi.org\/10.1038\/s41586-020-2918-0\u003C\/a\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DNature%26rft.volume%253D590%26rft.spage%253D140%26rft_id%253Dinfo%253Apmid%252Fhttp%253A%252F%252Fwww.n%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=http:\/\/www.n\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2021%2F04%2F06%2F2020.06.17.20133983.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E21.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-21-1\u0022 title=\u0022View reference 21. in text\u0022 id=\u0022ref-21\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2020.06.17.20133983v2.21\u0022 data-doi=\u002210.15585\/mmwr.mm6929a1\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ERazzaghi\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EH\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EWang\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EY\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ELu\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EH\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EEstimated County-Level Prevalence of Selected Underlying Medical Conditions Associated with Increased Risk for Severe COVID-19 Illness \u2014 United States, 2018\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EMMWR Morb Mortal Wkly Rep\u003C\/abbr\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2020\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E69\u003C\/span\u003E:\u003Cspan class=\u0022cit-fpage\u0022\u003E945\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E950\u003C\/span\u003E. DOI: \u003Ca href=\u0022http:\/\/dx.doi.org\/10.15585\/mmwr.mm6929a1\u0022\u003Ehttp:\/\/dx.doi.org\/10.15585\/mmwr.mm6929a1\u003C\/a\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DMMWR%2BMorb%2BMortal%2BWkly%2BRep%26rft.volume%253D69%26rft.spage%253D945%26rft_id%253Dinfo%253Adoi%252F10.15585%252Fmmwr.mm6929a1%26rft_id%253Dinfo%253Apmid%252Fhttp%253A%252F%252Fwww.n%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.15585\/mmwr.mm6929a1\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=http:\/\/www.n\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2021%2F04%2F06%2F2020.06.17.20133983.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E22.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-22-1\u0022 title=\u0022View reference 22. in text\u0022 id=\u0022ref-22\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-web\u0022 id=\u0022cit-2020.06.17.20133983v2.22\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth cit-collab\u0022\u003EStan Development Team. RStan: the R interface to Stan. 2018 R package version 2.17.3\u003C\/span\u003E. \u003Ca href=\u0022http:\/\/mc-stan.org\u0022\u003Ehttp:\/\/mc-stan.org\u003C\/a\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003C\/ol\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section ref-list\u0022 id=\u0022ref-list-2\u0022\u003E\u003Ch2 class=\u0022\u0022\u003ECitations\u003C\/h2\u003E\u003Col class=\u0022cit-list ref-use-labels\u0022\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E1.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-23-1\u0022 title=\u0022View reference 1. in text\u0022 id=\u0022ref-23\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-web\u0022 id=\u0022cit-2020.06.17.20133983v2.23\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth cit-collab\u0022\u003ENCHS\u003C\/span\u003E. \u003Cspan class=\u0022cit-source\u0022\u003EProvisional COVID-19 Death Counts by Sex, Age, and State\u003C\/span\u003E. Retrieved from: \u003Ca href=\u0022https:\/\/data.cdc.gov\/NCHS\/Provisional-COVID-19-Death-Counts-by-Sex-Age-and-S\/9bhg-hcku\u0022\u003Ehttps:\/\/data.cdc.gov\/NCHS\/Provisional-COVID-19-Death-Counts-by-Sex-Age-and-S\/9bhg-hcku\u003C\/a\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E2.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-24-1\u0022 title=\u0022View reference 2. in text\u0022 id=\u0022ref-24\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2020.06.17.20133983v2.24\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EO\u2019Driscoll\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EM.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ERibeiro Dos Santos\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EG.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EWang\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EL.\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EAge-specific mortality and immunity patterns of SARS-CoV-2\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003ENature\u003C\/abbr\u003E\u003Cspan class=\u0022cit-vol\u0022\u003E590\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E140\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E145\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2021\u003C\/span\u003E). \u003Ca href=\u0022https:\/\/doi.org\/10.1038\/s41586-020-2918-0\u0022\u003Ehttps:\/\/doi.org\/10.1038\/s41586-020-2918-0\u003C\/a\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DNature%26rft.volume%253D590%26rft.spage%253D140%26rft_id%253Dinfo%253Apmid%252Fhttp%253A%252F%252Fwww.n%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=http:\/\/www.n\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2021%2F04%2F06%2F2020.06.17.20133983.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E3.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-25-1\u0022 title=\u0022View reference 3. in text\u0022 id=\u0022ref-25\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2020.06.17.20133983v2.25\u0022 data-doi=\u002210.15585\/mmwr.mm6929a1\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ERazzaghi\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EH\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EWang\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EY\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ELu\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EH\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EEstimated County-Level Prevalence of Selected Underlying Medical Conditions Associated with Increased Risk for Severe COVID-19 Illness \u2014 United States, 2018\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EMMWR Morb Mortal Wkly Rep\u003C\/abbr\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2020\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E69\u003C\/span\u003E:\u003Cspan class=\u0022cit-fpage\u0022\u003E945\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E950\u003C\/span\u003E. DOI: \u003Ca href=\u0022http:\/\/dx.doi.org\/10.15585\/mmwr.mm6929a1\u0022\u003Ehttp:\/\/dx.doi.org\/10.15585\/mmwr.mm6929a1\u003C\/a\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DMMWR%2BMorb%2BMortal%2BWkly%2BRep%26rft.volume%253D69%26rft.spage%253D945%26rft_id%253Dinfo%253Adoi%252F10.15585%252Fmmwr.mm6929a1%26rft_id%253Dinfo%253Apmid%252Fhttp%253A%252F%252Fwww.n%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.15585\/mmwr.mm6929a1\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=http:\/\/www.n\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2021%2F04%2F06%2F2020.06.17.20133983.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E4.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-26-1\u0022 title=\u0022View reference 4. in text\u0022 id=\u0022ref-26\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2020.06.17.20133983v2.26\u0022 data-doi=\u002210.1038\/nbt.3820\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EDi Tommaso\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EP.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EChatzou\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EM.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EFloden\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EE.\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003ENextflow enables reproducible computational workflows\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003ENat Biotechnol\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E35\u003C\/span\u003E, \u003Cspan class=\u0022cit-fpage\u0022\u003E316\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E319\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2017\u003C\/span\u003E). \u003Ca href=\u0022https:\/\/doi.org\/10.1038\/nbt.3820\u0022\u003Ehttps:\/\/doi.org\/10.1038\/nbt.3820\u003C\/a\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DNat%2BBiotechnol%26rft.volume%253D35%26rft.spage%253D316%26rft_id%253Dinfo%253Adoi%252F10.1038%252Fnbt.3820%26rft_id%253Dinfo%253Apmid%252F28398311%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1038\/nbt.3820\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=28398311\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2021%2F04%2F06%2F2020.06.17.20133983.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003C\/ol\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section ref-list\u0022 id=\u0022ref-list-3\u0022\u003E\u003Ch2 class=\u0022\u0022\u003ECitations\u003C\/h2\u003E\u003Col class=\u0022cit-list ref-use-labels\u0022\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E1.\u003C\/span\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal no-rev-xref\u0022 id=\u0022cit-2020.06.17.20133983v2.27\u0022 data-doi=\u002210.7326\/M20-3012\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EHe\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EX.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ELau\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EE.H.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EWu\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EP.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EDeng\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EX.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EWang\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EJ.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EHao\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EX.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ELau\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EY.C.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EWong\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EJ.Y.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EGuan\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EY.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ETan\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EX.\u003C\/span\u003E\u003C\/span\u003E and \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EMo\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EX.\u003C\/span\u003E\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2020\u003C\/span\u003E). \u003Cspan class=\u0022cit-article-title\u0022\u003ETemporal dynamics in viral shedding and transmissibility of COVID-19\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003ENature medicine\u003C\/abbr\u003E, \u003Cspan class=\u0022cit-vol\u0022\u003E26\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E5\u003C\/span\u003E), pp.\u003Cspan class=\u0022cit-fpage\u0022\u003E672\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E675\u003C\/span\u003E.\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DNature%2Bmedicine%26rft.volume%253D26%26rft.spage%253D672%26rft_id%253Dinfo%253Adoi%252F10.7326%252FM20-3012%26rft_id%253Dinfo%253Apmid%252Fhttp%253A%252F%252Fwww.n%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.7326\/M20-3012\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=http:\/\/www.n\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2021%2F04%2F06%2F2020.06.17.20133983.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E2.\u003C\/span\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal no-rev-xref\u0022 id=\u0022cit-2020.06.17.20133983v2.28\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EK\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EMizumoto\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EK\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EKagaya\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EA\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EZarebski\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EG\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EChowell\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-article-title\u0022\u003EEstimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EEur Surveill\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-vol\u0022\u003E5\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E10\u003C\/span\u003E): \u003Cspan class=\u0022cit-fpage\u0022\u003E2000180\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2020\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DEur%2BSurveill%26rft.volume%253D5%26rft.spage%253D2000180%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E3.\u003C\/span\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal no-rev-xref\u0022 id=\u0022cit-2020.06.17.20133983v2.29\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EPoletti\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EP.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ETirani\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EM.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ECereda\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ED.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ETrentini\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EF.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EGuzzetta\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EG.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ESabatino\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EG.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EMarziano\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EV.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ECastrofino\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EA.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EGrosso\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EF.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EDel Castillo\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EG.\u003C\/span\u003E\u003C\/span\u003E and \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EPiccarreta\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ER.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-pub-date\u0022\u003E2020\u003C\/span\u003E. \u003Cspan class=\u0022cit-article-title\u0022\u003EProbability of symptoms and critical disease after SARS-CoV-2 infection\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EarXiv preprint\u003C\/abbr\u003E\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-arxiv-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003EarXiv:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-arxiv\u0022\u003E2006.08471\u003C\/span\u003E.\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E4.\u003C\/span\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal no-rev-xref\u0022 id=\u0022cit-2020.06.17.20133983v2.30\u0022 data-doi=\u002210.7326\/M20-3012\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EOran\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ED.P.\u003C\/span\u003E\u003C\/span\u003E and \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ETopol\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EE.J.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-pub-date\u0022\u003E2020\u003C\/span\u003E. \u003Cspan class=\u0022cit-article-title\u0022\u003EPrevalence of asymptomatic SARS-CoV-2 infection: a narrative review\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EAnnals of internal medicine\u003C\/abbr\u003E, \u003Cspan class=\u0022cit-vol\u0022\u003E173\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E5\u003C\/span\u003E), pp.\u003Cspan class=\u0022cit-fpage\u0022\u003E362\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E367\u003C\/span\u003E.\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DAnnals%2Bof%2Binternal%2Bmedicine%26rft.volume%253D173%26rft.spage%253D362%26rft_id%253Dinfo%253Adoi%252F10.7326%252FM20-3012%26rft_id%253Dinfo%253Apmid%252Fhttp%253A%252F%252Fwww.n%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.7326\/M20-3012\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=http:\/\/www.n\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2021%2F04%2F06%2F2020.06.17.20133983.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E5.\u003C\/span\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal no-rev-xref\u0022 id=\u0022cit-2020.06.17.20133983v2.31\u0022 data-doi=\u002210.1016\/S1473-3099(20)30243-7\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ER\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EVerity\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ELC\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EOkell\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EI\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EDorigatti\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EP\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EWinskill\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EC\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EWhittaker\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EN\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EImai\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E, \u003Cspan class=\u0022cit-article-title\u0022\u003EEstimates of the severity of coronavirus disease 2019: a model-based analysis\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EThe Lancet Infectious Diseases\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E20\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E6\u003C\/span\u003E): \u003Cspan class=\u0022cit-fpage\u0022\u003E669\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E677\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2020\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DThe%2BLancet%2BInfectious%2BDiseases%26rft.volume%253D20%26rft.spage%253D669%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS1473-3099%252820%252930243-7%26rft_id%253Dinfo%253Apmid%252F32240634%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1016\/S1473-3099(20)30243-7\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=32240634\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2021%2F04%2F06%2F2020.06.17.20133983.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E6.\u003C\/span\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal no-rev-xref\u0022 id=\u0022cit-2020.06.17.20133983v2.32\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EO\u2019Driscoll\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EM.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EDos Santos\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EG.R.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EWang\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EL.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ECummings\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ED.A.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EAzman\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EA.S.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EPaireau\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EJ.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EFontanet\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EA.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ECauchemez\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ES.\u003C\/span\u003E\u003C\/span\u003E and \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ESalje\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EH.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-pub-date\u0022\u003E2020\u003C\/span\u003E. \u003Cspan class=\u0022cit-article-title\u0022\u003EAge-specific mortality and immunity patterns of SARS-CoV-2\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003ENature\u003C\/abbr\u003E, pp.\u003Cspan class=\u0022cit-fpage\u0022\u003E1\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E6\u003C\/span\u003E.\u2019\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E7.\u003C\/span\u003E\u003Cdiv class=\u0022cit ref-cit ref-web no-rev-xref\u0022 id=\u0022cit-2020.06.17.20133983v2.33\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth cit-collab\u0022\u003ECOVID-19 Pandemic Planning Scenarios\u003C\/span\u003E. Retrieved from: \u003Ca href=\u0022https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/hcp\/planning-scenarios.html\u0022\u003Ehttps:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/hcp\/planning-scenarios.html\u003C\/a\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E8.\u003C\/span\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal no-rev-xref\u0022 id=\u0022cit-2020.06.17.20133983v2.34\u0022 data-doi=\u002210.1136\/bmjopen-2020-039652\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EMcAloon\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EC.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ECollins\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003E\u00c1.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EHunt\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EK.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EBarber\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EA.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EByrne\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EA.W.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EButler\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EF.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ECasey\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EM.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EGriffin\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EJ.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ELane\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EE.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EMcEvoy\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ED.\u003C\/span\u003E\u003C\/span\u003E and \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EWall\u003C\/span\u003E,  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EP.\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-pub-date\u0022\u003E2020\u003C\/span\u003E. \u003Cspan class=\u0022cit-article-title\u0022\u003EIncubation period of COVID-19: a rapid systematic review and meta-analysis of observational research\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EBMJ open\u003C\/abbr\u003E, \u003Cspan class=\u0022cit-vol\u0022\u003E10\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E8\u003C\/span\u003E), p.\u003Cspan class=\u0022cit-fpage\u0022\u003Ee039652\u003C\/span\u003E.\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DBMJ%2Bopen%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmjopen-2020-039652%26rft_id%253Dinfo%253Apmid%252F32801208%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/ijlink\/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NzoiYm1qb3BlbiI7czo1OiJyZXNpZCI7czoxMjoiMTAvOC9lMDM5NjUyIjtzOjQ6ImF0b20iO3M6NTA6Ii9tZWRyeGl2L2Vhcmx5LzIwMjEvMDQvMDYvMjAyMC4wNi4xNy4yMDEzMzk4My5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-ijlink\u0022\u003E\u003Cspan\u003E\u003Cspan class=\u0022cit-reflinks-abstract\u0022\u003EAbstract\u003C\/span\u003E\u003Cspan class=\u0022cit-sep cit-reflinks-variant-name-sep\u0022\u003E\/\u003C\/span\u003E\u003Cspan class=\u0022cit-reflinks-full-text\u0022\u003E\u003Cspan class=\u0022free-full-text\u0022\u003EFREE \u003C\/span\u003EFull Text\u003C\/span\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E9.\u003C\/span\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal no-rev-xref\u0022 id=\u0022cit-2020.06.17.20133983v2.35\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth cit-collab\u0022\u003ECDC COVID-19 Response Team, Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) \u2014 United States, February 12\u2013March 16, 2020\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EMMWR Morb Mortal Wkly Rep\u003C\/abbr\u003E; \u003Cspan class=\u0022cit-vol\u0022\u003E69\u003C\/span\u003E:\u003Cspan class=\u0022cit-fpage\u0022\u003E343\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E346\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2020\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DMMWR%2BMorb%2BMortal%2BWkly%2BRep%26rft.volume%253D69%26rft.spage%253D343%26rft_id%253Dinfo%253Apmid%252Fhttp%253A%252F%252Fwww.n%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=http:\/\/www.n\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2021%2F04%2F06%2F2020.06.17.20133983.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E10.\u003C\/span\u003E\u003Cdiv class=\u0022cit ref-cit ref-web no-rev-xref\u0022 id=\u0022cit-2020.06.17.20133983v2.36\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth cit-collab\u0022\u003ESanta Clara County COVID-19 Testing Dashboard\u003C\/span\u003E. Available at: \u003Ca href=\u0022https:\/\/www.sccgov.org\/sites\/covid19\/Pages\/dashboard.aspx#testing\u0022\u003Ehttps:\/\/www.sccgov.org\/sites\/covid19\/Pages\/dashboard.aspx#testing\u003C\/a\u003E [Accessed \u003Cspan class=\u0022cit-date-in-citation\u0022\u003EApril 8, 2020\u003C\/span\u003E]\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003C\/ol\u003E\u003C\/div\u003E\u003Cspan class=\u0022highwire-journal-article-marker-end\u0022\u003E\u003C\/span\u003E\u003C\/div\u003E\u003Cspan class=\u0022related-urls\u0022\u003E\u003C\/span\u003E\u003C\/div\u003E\u003C\/div\u003E  \u003C\/div\u003E\n\n  \n  \u003C\/div\u003E\n\u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E\n\u003C\/div\u003E\u003Cscript type=\u0022text\/javascript\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/js\/js_zP7WWIfzbyzvaM63L39cNV2juU_1XVH7wduFK9gcMNI.js\u0022\u003E\u003C\/script\u003E\n\u003C\/body\u003E\u003C\/html\u003E"}